<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Oxid Med Cell Longev</span><span class="iso-abbrev" title="iso-abbrev">Oxid Med Cell Longev</span><span class="publisher-id" title="publisher-id">OMCL</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Oxidative Medicine and Cellular Longevity</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1942-0900</span><span class="issn-epub" tagx="issn" title="issn-epub">1942-0994</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Hindawi</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7790557">7790557</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1155/2020/8413713">10.1155/2020/8413713</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Pleiotropic Properties of Amphiphilic Dihydropyridines, Dihydropyridones, and Aminovinylcarbonyl Compounds</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-2695-266X</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">Martins</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-1004-6796</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smits</span><span class="given-names" tagx="given-names" title="given-names">Rufus</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-3768-658X</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sipola</span><span class="given-names" tagx="given-names" title="given-names">Anda</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-4654-8835</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vigante</span><span class="given-names" tagx="given-names" title="given-names">Brigita</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-5022-5206</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Domracheva</span><span class="given-names" tagx="given-names" title="given-names">Ilona</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-0567-9801</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovska</span><span class="given-names" tagx="given-names" title="given-names">Baiba</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-6827-7290</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muhamadejev</span><span class="given-names" tagx="given-names" title="given-names">Ruslan</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-8558-601X</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">Karlis</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-8746-9295</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">Mara</span></span><a href="#I2"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-5517-1240</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sobolev</span><span class="given-names" tagx="given-names" title="given-names">Arkadij</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-3071-6056</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duburs</span><span class="given-names" tagx="given-names" title="given-names">Gunars</span></span><span class="email" tagx="email" title="email">gduburs@osi.lv</span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-2187-5693</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">Aiva</span></span><span class="email" tagx="email" title="email">aiva@osi.lv</span><a href="#I1"><sup>1</sup></a></span></div><span class="citation_author_institution" id="I1">[], <sup>1</sup></span><span class="citation_author_institution" id="I2">[], <sup>2</sup></span><div class="author-notes" title="author-notes"> <div class="fn-type-other" title="other"> <p>Academic Editor: Sasanka Chakrabarti</p> </div> </div><span class="pub-date-collection" title="pub-date-collection">collection: <span>2020</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-12-12</span></span><span class="volume" tagx="volume" title="volume">2020</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">8413713</span><span class="history" title="history"><span class="received" title="received">received: 2020-7-23</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-10-9</span><span class="accepted" title="accepted">accepted: 2020-11-10</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>Three groups of synthetic lipids are chosen for studies: (1) 1,4-dihydropyridines (1,4-DHPs) containing two cationic moieties and their analogues; (2) 3,4-dihydro-2(1<i>H</i>)-pyridones containing a cationic moiety; and (3) acyclic, open-chain analogues, i.e., 2-amino-3-alkoxycarbonylalkylammonium derivatives. 1,4-DHPs possessing dodecyl alkyl chains in the ester groups in positions 3 and 5 and cationic nitrogen-containing groups in positions 2 and 6 have high cytotoxicity in cancer cells HT-1080 (human lung fibrosarcoma) and MH-22A (mouse hepatoma), but low cytotoxicity in the noncancerous NIH3T3 cells (mouse embryonic fibroblast). On the contrary, similar compounds having short (methyl, ethyl, or propoxyethyl) chains in the ester groups in positions 3 and 5 lack cytotoxicity in the cancer cells HT-1080 and MH-22A even at high doses. Inclusion of fluorine atoms in the alkyl chains in positions 3 and 5 of the DHP cycle decreases the cytotoxicity of the mentioned compounds. Structurally related dihydropyridones with a polar head group are substantially more toxic to normal and cancerous cells than the DHP analogues. Open-chain analogues of DHP lipids comprise the same conjugated aminovinylcarbonyl moiety and possess anticancer activity, but they also have high basal cytotoxicity. Electrochemical oxidation data demonstrate that oxidation potentials of selected compounds are in the range of 1.6â€"1.7â€‰V for cationic 1,4-DHP, 2.0â€"2.4â€‰V for cationic 3,4-dihydropyridones, and 1.2â€"1.5â€‰V for 2-amino-3-alkoxycarbonylalkylammonium derivatives. Furthermore, the tested cationic 1,4-DHP amphiphiles possess antiradical activity. Molecular topological polar surface area values for the tested compounds were defined in accordance with the main fragments of compound structures. The determined log<i>P</i> values were highest for dodecyl ester groups in positions 3 and 5 of the 1,4-DHP and lowest for short alkyl chain-containing amphiphiles.</p> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source">
EuroNanoMed2 Project INNOCENT</div> </div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source">
PostDocLatvia Project</div><span class="award-id" tagx="award-id" title="award-id">Nr.1.1.1.2/VIAA/2/18/371</span></div> </div> </div> </div> <div class="body" title="body"> <div class="1.introduction" title="sec"> <div class="title" tagx="title" title="title">
1. Introduction</div> <p>For a long time, liposomes have been considered to have a role in the encapsulation of toxic drugs (mainly anticancer drugs) into liposomal drug delivery systems which are supposed to be inert, having no pharmacological or chemotherapeutical activity <i>per se</i> [<a href="#B1">1</a>]. The properties of liposomes are mainly dependent on the characteristics of their constituent lipids.</p> <p>Lipids and liposomal agents as liposome-forming building blocks depending on their physicochemical properties can influence the immune system. For the development of new liposomal systems, it is important to perform analysis on the liposome-forming lipid properties with an emphasis on toxicity to healthy tissues and immune responses [<a href="#B2">2</a>]. Synthetic cationic amphiphilic bilayers can act as gene, vaccine, or drug carriers; at the same time, they can interact with negatively charged prokaryotic or eukaryotic cells, causing cell adhesion and loss of cell viability. Lipids and liposomes deserve to be investigated as potential drugs [<a href="#B3">3</a>]. Cytotoxicity of cationic liposomes is a significant property to be checked [<a href="#B4">4</a>].</p> <p>Liposomes may induce oxidative damage to normal tissues [<a href="#B5">5</a>]. Reactive oxygen species (ROS) and lipid peroxidation products not only are cytotoxic but may also perform and modulate signal transduction in cells [<a href="#B6">6</a>]. It was demonstrated that the levels of ROS and the activity of scavenging/antioxidant enzymes in drug-resistant cancer cells are typically increased compared to nonresistant cancer and normal cells. Thereby, multidrug-resistant (MDR) cancer cells may be more susceptible to alterations in ROS levels. Numerous studies suggest that compounds modulating cellular ROS levels can enhance MDR cancer cell death and sensitize MDR cancer cells to certain chemotherapeutic drugs [<a href="#B7">7</a>]. It was concluded that unspecific elimination of ROS by use of low molecular mass antioxidants was not successful for disease initiation and progression. However, controlling specific ROS-mediated signaling pathways by selective targeting offers a perspective for more refined redox medicine in the future [<a href="#B8">8</a>]. Additional antioxidant activity (antiradical activity) could be beneficial as it would protect cells and organisms in case of oxidative stress or, in general, be involved in the process of redox regulation and master switch systems [<a href="#B9">9</a>]. In this way, 1,4-dihydropyridines, being a group of synthetic antioxidants, could be used for the modulation of cellular redox signaling. Lipids reveal cancer cell-selective cytotoxicitiesâ€"they are less cytotoxic in noncancerous healthy cells [<a href="#B10">10</a>]. Evaluation of the cytotoxicity of nanoparticles and their components is crucial for the accurate interpretation of pharmacological activities [<a href="#B11">11</a>]. Nonviral synthetic lipid vectors may interact with biomolecules through functional moieties (biosignature), resulting in biological impacts: intrinsic genomic and nongenomic effects [<a href="#B12">12</a>].</p> <p>Our research group has developed liposome-forming cationic 1,4-dihydropyridine (1,4-DHP) amphiphiles capable of transfecting pDNA into different cell lines <i>in vitro</i>. To assess the influence of different molecular architectures on gene delivery properties, numerous 1,4-DHP amphiphiles were studied [<a href="#B13">13</a>â€"<a href="#B15">15</a>]. Besides, some of these amphiphilic compounds revealed anticancer activity in HT-1080 and MH-22A cells and antiradical activities (27â€"40% in DPPH tests) [<a href="#B13">13</a>, <a href="#B16">16</a>]. The remarkable increase of N-H acidity (up to pKa ~7â€"8) in the DHP cycle is the basis for its buffering activity in these types of gene transfection agents [<a href="#B17">17</a>].</p> <p>Recently, it was demonstrated that 4-(N-alkylpyridinium)-1,4-dihydropyridines possess toxicity in Gram-positive and Gram-negative bacteria species and eukaryotic microorganisms [<a href="#B18">18</a>]. The abovementioned 4-(N-alkylpyridinium)-1,4-dihydropyridines also possess calcium channel-blocking and antioxidant activities [<a href="#B19">19</a>].</p> <p>In this work, we chose amphiphilic dihydropyridine derivatives as synthetic lipids and their structural analogues as objects to study pleiotropic activities. The cytotoxic properties of 3 types of amphiphilic compounds in 3 cell lines, namely, normal NIH3T3 (mouse embryonic fibroblast), cancerous HT-1080 (human lung fibrosarcoma), and MH-22A (mouse hepatoma), were evaluated. The studied compounds could be divided into 3 groups according to their structural fragments: (a) 1,4-dihydropyridines containing two cationic moieties as a conjugated cyclic bis(<i>Î²</i>-carbonylvinyl)amino system and some structurally related compounds; (b) 3,4-dihydro-2(1<i>H</i>)-pyridones containing a cationic moiety as an isomeric 3,4-dihydropyridine structure with an additional intracyclic carbonyl groupâ€"a N-<i>Î²</i>-carbonylvinylamido system; and (c) 2-amino-3-alkoxycarbonylalkylammonium derivatives as acyclic, open-chain <i>Î²</i>-aminovinylcarbonyl systems. Lipophilicity of the selected compounds was characterized using log<i>P</i> and molecular topological polar surface area calculations. Evaluation of electrochemical oxidation potentials of the selected compounds was also performed.</p> </div> <div class="2.materialsandmethods" title="sec"> <div class="title" tagx="title" title="title">
2. Materials and Methods</div> <div class="2.1.chemistry" title="sec"> <div class="title" tagx="title" title="title">
2.1. Chemistry</div> <p>More detailed descriptions of synthetic procedures and characterization of the original unpublished intermediates and compounds are described in the Supplementary data.</p> <div class="2.1.1.synthesisofcationic1,4-dihydropyridines1â€" title="sec"> <div class="title" tagx="title" title="title">
2.1.1. Synthesis of Cationic 1,4-Dihydropyridines <b>1â€"26</b></div> <p>Briefly, the elaborated synthesis of the cationic 1,4-DHP <b>1</b>â€"<b>7</b>, <b>9</b>â€"<b>25</b> involved three sequential steps. The first step was the synthesis of the corresponding 2,6-dimethyl 1,4-DHP derivative in a two-component Hantzsch-type cyclization using 1.0â€‰eq of the corresponding aldehyde, 1.2â€‰eq of an ammonia source, and 2.0â€‰eq of the corresponding acetoacetate for symmetrically substituted 1,4-DHP derivatives or 1â€‰eq of the corresponding acetoacetate and 1.0â€‰eq of the corresponding 3-aminobut-2-enoate for unsymmetrically substituted ones. The second step involved the bromination of the methyl groups of the 2,6-dimethyl-1,4-DHP derivative with N-bromosuccinimide, and the third step was the nucleophilic substitution of bromine of the 2,6-dibromomethylene-1,4-DHP by N-heterocycles or amines yielding the target compounds. The first step for the synthesis of the parent 1,4-dihydropyridine in the case of compound <b>26</b> involved the reaction between 1.0â€‰eq of the corresponding aldehyde, 2.4â€‰eq of ammonium acetate, and 4.0â€‰eq of the corresponding acetoacetate. More detailed synthetic procedures and characterization of the original compounds are described in the Supplementary data.</p> </div> <div class="2.1.2.synthesisofcompound8[20]" title="sec"> <div class="title" tagx="title" title="title">
2.1.2. Synthesis of Compound <b>8</b> [<a href="#B20">20</a>]</div> <p>Briefly, the condensation of ethyl 4-chloroacetoacetate with glyoxylic acid monohydrate in the presence of piperidine/acetate provided (<i>E,Z</i>)-2-(2-chloroacetyl)-but-2-enedioic acid 1-ethyl ester, which was used in the next reaction with ethyl 3-amino-4-chlorobut-2-enoate. The obtained 3,5-diethyl 2,6-bis(chloromethyl)-1,4-dihydropyridine-3,4,5-tricarboxylate was esterified with methanol to afford the parent 2,6-dichloromethylene-1,4-DHP. The target compound <b>8</b> was obtained <i>via</i> nucleophilic substitution of chlorine by pyridine in the presence of potassium iodide.</p> </div> <div class="2.1.3.synthesisofcationicpyridine27[14]" title="sec"> <div class="title" tagx="title" title="title">
2.1.3. Synthesis of Cationic Pyridine <b>27</b> [<a href="#B14">14</a>]</div> <p>Briefly, the corresponding 2,6-dibromomethylene-1,4-DHP was oxidized by HNO<sub>2</sub> followed by nucleophilic substitution of bromine with pyridine to give the target compound <b>27</b>.</p> </div> <div class="2.1.4.synthesisofcationic3,4-dihydro-2(1h)-pyridones28â€" title="sec"> <div class="title" tagx="title" title="title">
2.1.4. Synthesis of Cationic 3,4-Dihydro-2(1<i>H</i>)-pyridones <b>28</b>â€"<b>38</b></div> <p>Briefly, 3,4-dihydro-2(1<i>H</i>)-pyridone synthesis employed a four-component reaction using Meldrum's acid by a heterocyclization with the corresponding <i>Î²</i>-ketoester and the corresponding aldehyde. The obtained 3,4-dihydro-2(1<i>H</i>)-pyridones were treated with bromine giving the respective 6-methylbromides, which in subsequent reaction with pyridine or amine provided the target compounds <b>28</b>â€"<b>38</b>.</p> </div> <div class="2.1.5.synthesisof2-amino-3-alkoxycarbonylalkylammoniumhalides39â€" title="sec"> <div class="title" tagx="title" title="title">
2.1.5. Synthesis of 2-Amino-3-alkoxycarbonylalkylammonium Halides <b>39</b>â€"<b>48</b></div> <p>Briefly, the first step included the transesterification of the commercially available ethyl 4-chloroacetoacetate with a corresponding carbinol without solvent by azeotropic removal of ethanol. The further reaction of the corresponding 4-chloro-3-oxobutanoates with ammonium acetate led to enaminoesters, which were used for quaternization by tertiary amines or heterocycles giving the target compounds <b>39</b>â€"<b>48</b>. Potassium iodide or sodium bromide additives were used for obtaining the corresponding iodides or bromides.</p> </div> </div> <div class="2.2.experimentsforevaluationofelectrochemicaloxidationpotentials" title="sec"> <div class="title" tagx="title" title="title">
2.2. Experiments for Evaluation of Electrochemical Oxidation Potentials</div> <p>Cyclic voltammetry experiments were carried out on a PARSTAT 2273 electrochemical system. A stationary glassy carbon disk electrode (<i>d</i> = 0.5â€‰mm) served as the working electrode, while the counterelectrode was a Pt wire. The oxidation potentials were measured relative to a Ag/Ag<sup>+</sup> reference electrode. Acetonitrile was dried over P<sub>2</sub>O<sub>5</sub> and distilled; the distillate was stored over CaH<sub>2</sub> and redistilled just before use. Recrystallized tetrabutylammonium tetrafluoroborate (TBABF<sub>4</sub>) was used as a supporting electrolyte at 0.1â€‰M concentration.</p> </div> <div class="2.3.determinationoflogpandmoleculartopologicalpolarsurfacearea" title="sec"> <div class="title" tagx="title" title="title">
2.3. Determination of Log<i>P</i> and Molecular Topological Polar Surface Area</div> <p>Log<i>P</i> and Topological Polar Surface Area (TPSA) values were calculated with the Chem3D Ultra 19 program (PerkinElmer Informatics). For log<i>P</i> calculations, the Molecular Networks module was used on single-molecule compounds (salts were taken as cations).</p> </div> <div class="2.4.cytotoxicity" title="sec"> <div class="title" tagx="title" title="title">
2.4. Cytotoxicity</div> <p>Cytotoxicity of the compounds was determined on HT-1080 (human lung fibrosarcoma) and MH-22A (mouse hepatoma) cell lines and on the normal NIH3T3 (mouse embryonic fibroblast) cell line. IC<sub>50</sub> is the compound concentration (<i>Î¼</i>g/ml) at which 50% of the cells die. CV is a triarylmethane dye that can bind to ribose-type molecules such as DNA in nuclei. CV staining can be used to quantify the total DNA of the remaining population and thus is used to determine the number of live cells based on the concentration of the dye which remains after staining. MTT is a standard colorimetric assay used to measure cellular proliferation. Yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is reduced to purple formazan in the mitochondria of living cells.</p> <p>Reduction takes place only when mitochondrial reductase enzymes are active, and therefore, conversion is directly related to the number of viable cells which can be quantified by the absorbance of the solution (between <i>Î»</i> = 500 and 600â€‰nm) using a spectrophotometer.</p> </div> <div class="2.5.cellcultureandmeasurementofcellviability" title="sec"> <div class="title" tagx="title" title="title">
2.5. Cell Culture and Measurement of Cell Viability</div> <p>Tumor cell lines HT-1080 (human connective tissue fibrosarcoma, ATCCÂ® CCL-121â"¢) and MH-22A (mouse hepatocarcinoma, ECACC, cat. Nr. 96121721) were used.</p> <p>HT-1080 and MH-22A cells were seeded in 96-well plates in Dulbecco's modified Eagle's (DMEM) medium containing 10% fetal bovine serum and 4â€‰mM L-glutamine, without antibiotics, and cultivated for 72â€‰h by exposure to different concentrations of compounds. Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT). In brief, after incubating with compounds, the culture medium was removed and fresh medium with 0.2â€‰mg/ml MTT was added in each well of the plate. After incubation (3â€‰h, 37Â°C, 5% CO<sub>2</sub>), the medium with MTT was removed, and 200â€‰<i>Î¼</i>l DMSO was added at once to each sample. The samples were tested at 540â€‰nm on a Tecan Infinite M1000 multiplate reader. The IC<sub>50</sub> was calculated using the program GraphPad PrismÂ® 3.0.</p> <p>For the CV assay, cells were stained with 0.05% crystal violet (Sigma-Aldrich) in 30% methanol for 20 minutes at room temperature. After incubation, the staining solution was removed. The cells were washed 4 times with water. For dye solubilization, 200â€‰<i>Î¼</i>l of a solubilizing solution (0.1â€‰M citrate buffer, pHâ€‰4.2 in 50% ethanol; 1â€‰:â€‰1 <i>v</i>/<i>v</i>) was added. The absorbance of the solution was measured using a Tecan Infinite M1000 multiplate spectrophotometer at a wavelength of 570â€‰nm [<a href="#B21">21</a>].</p> </div> <div class="2.6.basalcytotoxicitytest" title="sec"> <div class="title" tagx="title" title="title">
2.6. Basal Cytotoxicity Test</div> <p>The Neutral Red Uptake (NRU) assay was performed according to the standard protocol of Stokes et al. [<a href="#B22">22</a>] modified by a NICEATM-ECVAM validation study [<a href="#B23">23</a>]. The NRU cytotoxicity assay procedure is based on the ability of viable cells to incorporate and bind neutral red, a supravital dye.</p> <p>Balb/c NIH 3T3 (mouse Swiss albino embryo fibroblast, ATCCÂ® CRL-1658â"¢) cells (9000 cells/well) were placed into 96-well plates for 24â€‰h in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal bovine serum. Then, the cells were exposed to the test compound over a range of seven concentrations (1000, 316, 100, 31, 10, 3, and 1â€‰<i>Î¼</i>g/ml) for 24â€‰h. Untreated cells were used as a control. After 24â€‰h, the medium was removed from all plates. Then, 150â€‰<i>Î¼</i>l of neutral red solution was added (0.05â€‰mg/ml NR in DMEM 24â€‰h preincubated at 37Â°C and then filtered before use through a 0.22â€‰<i>Î¼</i>m syringe filter). Plates were incubated for 3â€‰h, and then, the cells were washed three times with PBS. The dye within viable cells was released by extraction with a mixture of acetic acid, ethanol, and water (1â€‰:â€‰50â€‰:â€‰49). The absorbance of neutral red was measured using a spectrophotometer multiplate reader (Tecan Infinite M1000) at 540â€‰nm. The optical density (OD) was calculated using the following formula: ODâ€‰(treatedâ€‰cells) Ã— 100/ODâ€‰(controlâ€‰cells). The IC<sub>50</sub> values were calculated using the GraphPad PrismÂ® 3.0 program.</p> </div> <div class="2.7.estimationofld50fromic50values" title="sec"> <div class="title" tagx="title" title="title">
2.7. Estimation of LD<sub>50</sub> from IC<sub>50</sub> Values</div> <p>Data from the <i>in vitro</i> tests were used for estimating the starting dose for acute oral systemic toxicity tests in the rodent. The <i>in vivo</i> starting dose is an estimated LD<sub>50</sub> value calculated by inserting the <i>in vitro</i>IC<sub>50</sub> value into a regression formula: logâ€‰LD<sub>50</sub>â€‰(mM/kg) = 0.439â€‰logâ€‰IC<sub>50</sub>â€‰(mM) + 0.621 [<a href="#B23">23</a>â€"<a href="#B25">25</a>]. The value is recalculated to mg/kg, and compounds are evaluated in accordance with 4 toxicity categories [<a href="#B26">26</a>]: category 1â€"LD<sub>50</sub> â‰¤ 5â€‰mg/kg (highly toxic); category 2â€"5 &amp;lt; LD<sub>50</sub> â‰¤ 50â€‰mg/kg (moderately toxic); category 3â€"50 &amp;lt; LD<sub>50</sub> â‰¤ 300â€‰mg/kg (slightly toxic); and category 4â€"300 &amp;lt; LD<sub>50</sub> â‰¤ 2000â€‰mg/kg (practically nontoxic). Using an alternative <i>in vitro</i> method allows the comparison between possibly toxic new compounds and selecting compounds for further study vastly reducing the number of animal experiments.</p> </div> </div> <div class="3.resultsanddiscussion" title="sec"> <div class="title" tagx="title" title="title">
3. Results and Discussion</div> <div class="3.1.structuresofcompounds" title="sec"> <div class="title" tagx="title" title="title">
3.1. Structures of Compounds</div> <p>The studied compounds could be divided into 3 groups considering structure fragments: </p><ol> <li> <p><i>1st group</i>: twenty-five representatives of two cationic moieties containing 1,4-dihydropyridines (compounds <b>1</b>â€"<b>25</b> in <a href="#tab1">Table 1</a>) and, additionally, four cationic moieties containing 1,4-dihydropyridine (compound <b>26</b> in <a href="#tab1">Table 1</a>) and one as an oxidized formâ€"two cationic moieties containing pyridine (compound <b>27</b> in <a href="#tab1">Table 1</a>)</p> </li> <li> <p><i>2nd group</i>: eleven representatives of 3,4-dihydro-2(1<i>H</i>)-pyridones containing a cationic moiety as an isomeric 3,4-dihydropyridine structure with an additional intracyclic carbonyl group, i.e., the N-<i>Î²</i>-carbonylvinylamido system (compounds <b>28</b>â€"<b>38</b> in <a href="#tab2">Table 2</a>)</p> </li> <li> <p><i>3rd group</i>: ten representatives of cationic 2-amino-3-alkoxycarbonylalkylammonium derivatives as acyclic, open-chain analogues of cyclic 1,4-DHPs (compounds <b>39</b>â€"<b>48</b> in <a href="#tab3">Table 3</a>)</p> </li> </ol> <p /> <p>These three groups were selected after analysis of their structure-activity relationships as synthetic lipid-like amphiphilic compounds. Previously, the 3rd group representativesâ€"(2-amino-3-alkoxycarbonylalkyl)trialkylammonium halidesâ€"were synthesized, and their ribonucleic acid (RNS) transfection activity was demonstrated [<a href="#B27">27</a>]. This group covers synthetic lipid-like compounds on the basis of a <i>Î²</i>-aminovinylcarbonyl (AVC) moiety: a conjugated pentade system connected with a lipophilic carbon atom chain and a cationic part (alkylammonium or pyridinium type). These compounds are proposed as an open-chain system compared to the cationic 1,4-DHP or pyridone heterocyclic systems. Structurally, the 2nd group moleculesâ€"the cationic pyridone derivativesâ€"are heterocycles which comprise a cyclic AVC system and an additional intracyclic carbonyl group and an extracyclic cation. Previously, the 1st group representativesâ€"1,4-DHP derivatives containing pyridinium moietiesâ€"were presented as promising tools for delivery of DNA into target cells [<a href="#B13">13</a>, <a href="#B14">14</a>, <a href="#B20">20</a>, <a href="#B28">28</a>]. It is noteworthy that, due to cross-conjugation of two AVC systems of the 1,4-DHP cycle, its N-H group is influenced by two electron-withdrawing vinylcarbonyls.</p> </div> <div class="3.2.synthesisoftheamphiphiles" title="sec"> <div class="title" tagx="title" title="title">
3.2. Synthesis of the Amphiphiles</div> <p>Synthesis of the amphiphiles was performed according to Schemes <a href="#sch1">1</a>â€"<a href="#sch4">4</a>.</p> <p>Previously, 3,5-bis(dodecyloxycarbonyl)-1,4-DHPs containing cationic moieties were elaborated as synthetic lipid-like compounds having promising gene delivery properties for DNA transfection; the basic structure-activity relationships have been verified for the cationic 1,4-DHP derivatives as gene delivery systems, and it has been shown that the molecular structure affected their self-assembling properties, pDNA-binding ability, and properties of the formed 1,4-DHP amphiphile-pDNA complexes [<a href="#B13">13</a>, <a href="#B15">15</a>, <a href="#B28">28</a>]. The synthetic procedure for the amphiphilic compounds <b>1</b>â€"<b>7</b>, <b>9</b>â€"<b>22</b>, and <b>26</b> is displayed in <a href="#sch1">Scheme 1</a><i>via</i> a multistep sequence. The first step was a Hantzsch synthesis of the parent compound 3,5-bis(alkoxycarbonyl)-2,6-dimethyl-4-phenyl-1,4-dihydropyridine. The second step was bromination of the 2,6-methyl groups with N-bromosuccinimide (NBS) [<a href="#B34">34</a>] resulting in the second parent compound 2,6-di(bromomethyl)-3,5-bis(alkoxycarbonyl)-4-phenyl-1,4-dihydropyridine. The final step was nucleophilic substitution of bromine in the 2,6-di(bromomethyl)-1,4-DHP by N-heterocycles or amines, which is facile and generally takes place in good yields.</p> <p>Additionally, for studies of targeted changes in the structure of corresponding dicationic compound <b>10</b>, which was found to be more active for DNA delivery among the tested 1,4-DHP amphiphiles [<a href="#B13">13</a>, <a href="#B15">15</a>, <a href="#B28">28</a>], 1,1â€²,1<sup>â€³</sup>,1â€´-((1,4-phenylenebis(3,5-bis((dodecyloxy)carbonyl)-1,4-dihydropyridine-4,2,6-triyl))tetrakis(methylene))tetrakis(pyridin-1-ium) tetrabromide (<b>26</b>) was synthesized as a double or a â€œdimericâ€� molecule of compound <b>10</b> and 1,1â€²-((3,5-bis(dodecyloxycarbonyl)-4-phenylpyridine-2,6-diyl)bis(methylene))-bis(pyridin-1-ium)dibromide (<b>27</b>) was prepared in accordance with what was reported in [<a href="#B14">14</a>] as the oxidized form of compound <b>10</b>. For evaluation of the anion influence on cytotoxicity, 1,1â€²-((3,5-bis((dodecyloxy)carbonyl)-4-phenyl-1,4-dihydropyridine-2,6-diyl)bis(methylene))bis(pyridin-1-ium) ditetrafluoroborate (<b>11</b>) was synthesized from compound <b>10</b> after treating with NH<sub>4</sub>BF<sub>4</sub>.</p> <p>The unsymmetrical 1,4-DHP amphiphile <b>23</b> was designed for analysis of the influence of mixed perfluorinated and alkyl ester moiety substituents on the properties of amphiphiles. The 1,4-DHP <b>23</b> molecule contains only one of the two esters as a perfluorinated ester moiety while the other is an alkyl esterâ€"the same as previous compounds. The synthetic procedure (<a href="#sch2">Scheme 2</a>) includes a reaction between an enamine and benzylidene in diglyme with inclusion of n-butylpyridinium chloride as a phase transfer catalyst (PTC) [<a href="#B35">35</a>] to affording the parent dodecyl 5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heptadecafluorododecyl 1,4-dihydro-2,6-dimethyl-4-phenylpyridine-3,5-dicarboxylate in 43% yield. Without the PTC, the yield was only 25%. Subsequent bromination with NBS formed the corresponding 2,6-dibromomethylene DHP which was used without further purification in nucleophilic substitution with pyridine yielding the unsymmetrical 1,4-DHP <b>23</b>.</p> <p>The 3,4-dihydro-2(1<i>H</i>)-pyridones (DHPDO) possess various pharmacological properties as <i>Î±</i>1a adrenergic receptor antagonists [<a href="#B36">36</a>], Rho-kinase inhibitors [<a href="#B37">37</a>], P<sub>2</sub>X<sub>7</sub> receptor antagonists [<a href="#B38">38</a>], or G-protein-coupled kinase receptor antagonists [<a href="#B39">39</a>]. Synthesis of 3,4-dihydro-2(1<i>H</i>)-pyridone amphiphiles <b>28</b>â€"<b>38</b> was performed according to <a href="#sch3">Scheme 3</a>. In this case, Meldrum's acid was used as the second dicarbonyl component in a Hantzsch-like reaction with heterocyclization, with a corresponding <i>Î²</i>-ketoester and a corresponding aldehyde in the presence of ammonium acetate in refluxing glacial acetic acid [<a href="#B40">40</a>]. The parent DHPDO solution in chloroform was treated with bromine affording the respective 6-bromomethyl-DHPDO, which on subsequent reaction with pyridine or N,N-dimethyldodecyl-1-amine in dry acetone yielded the corresponding amphiphilic DHPDO derivatives <b>28</b>â€"<b>38</b>.</p> <p>Typically, enaminones have been studied and used as precursors and synthons for the synthesis of novel heterocyclic systems: pyridines, pyrroles, pyrimidines, dihydropyridines, etc. [<a href="#B41">41</a>]. Therefore, up to now, most of the research in the field of enamines have been devoted to the elaboration of new strategies and synthetic methods, but lack biological studies [<a href="#B42">42</a>]. 2-Amino-3-alkoxycarbonylalkylammonium halides with long alkyl chains have appeared as a new class of enaminoesters and were elaborated as a transfection agent for RNS transfection [<a href="#B27">27</a>]. Also, structure analoguesâ€"alkyl acyl carnitine estersâ€"were synthesized and characterized as biocompatible cationic lipids for use in gene delivery [<a href="#B43">43</a>]. Cationic enaminoesters are stable solid compounds with remarkable solubility in water. The synthetic procedure for 2-amino-3-alkoxycarbonylalkylammonium halides <b>39</b>â€"<b>48</b> is provided in <a href="#sch4">Scheme 4</a>. Briefly, the first step included the transesterification of commercially available ethyl 4-chloroacetoacetate with the corresponding carbinol without solvent by azeotropic removal of ethanol. Further reaction of the corresponding 4-chloro-3-oxobutanoates with ammonium acetate led to the formation of enaminoesters, which were used for quaternization with tertiary amines or heterocycles by extended heating in a dry solvent. Potassium iodide or sodium bromide additives were used for obtaining the corresponding iodides or bromides.</p> <p>The perchlorates of amphiphiles <b>9</b>, <b>15</b>, <b>22</b>, <b>27</b>, and <b>32</b> were obtained from the corresponding bromides by treating with excess of conc. HClO<sub>4</sub> according to the procedure elaborated by Turovska et al. [<a href="#B44">44</a>]. In some cases, the perchlorates were used for obtaining solid salts while the corresponding bromides existed as oils, and it was not possible to isolate them from the reaction mixture.</p> <p>The full description of the synthesis and characterization of the original compounds in detail are given in the Supplementary data. Purity of the studied compounds was at least 97% according to high-performance liquid chromatography (HPLC) data.</p> </div> <div class="3.3.estimationofld50fromic50values" title="sec"> <div class="title" tagx="title" title="title">
3.3. Estimation of LD<sub>50</sub> from IC<sub>50</sub> Values</div> <p>It has been proposed that the equation from the correlation of IC<sub>50</sub> (the concentration of a substance that causes 50% toxicity <i>in vitro</i>) could be applied to estimate unknown LD<sub>50</sub> values for a new compound from IC<sub>50</sub> values measured as basal cytotoxicity <i>in vitro</i>. This estimated LD<sub>50</sub> gives prior information regarding compound properties and would be used to select promising compounds and a starting dose for <i>in vivo</i> experiments. The evaluation of cytotoxicity of the abovementioned 3 types of amphiphilic compounds <i>in vitro</i> was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT) and crystal violet (CV) assays on two monolayer tumor cell lines, namely, HT-1080 (human fibrosarcoma) and MH-22A (mouse hepatoma). Additionally, the compound influence on â€œnormalâ€� mouse fibroblasts (NIH3T3) was estimated for the studies of structure-activity relationships and exploration of the effect of substituents. The results are presented in Tables <a href="#tab1">1</a><a href="#tab2" />â€"<a href="#tab3">3</a>. Studies of cytotoxicity of the amphiphilic self-assembling compounds revealed certain regularities.</p> </div> <div class="3.4.analysisofstructure-activityrelationships" title="sec"> <div class="title" tagx="title" title="title">
3.4. Analysis of Structure-Activity Relationships</div> <div class="3.4.1.twocationicmoietiescontaining1,4-dhpamphiphiles(table1)" title="sec"> <div class="title" tagx="title" title="title">
3.4.1. Two Cationic Moieties Containing 1,4-DHP Amphiphiles (<a href="#tab1">Table 1</a>)</div> <p><i>(1) Modification of Ester Alkyl Groups</i>. Compounds possessing short alkyl chains in the ester groups at positions 3 and 5 of the dihydropyridine ring and organic heterocyclic cations in the methylene groups in positions 2 and 6 had very low cytotoxicity in cancer cell lines HT-1080 and MH-22A and high calculated LD<sub>50</sub> values (comp. <b>1</b>â€"<b>9</b>). It means that the compounds were almost inert to the noncancerous cell line NIH3T3 and cancer cell lines HT-1080 and MH-22A. This refers to several groups of the mentioned type of compounds possessing short alkyls in 3,5-ester substituents (methyl, ethyl, and also the more elongated propoxyethyl groups): comp. <b>9</b>, <b>1</b>, <b>6</b>, <b>8</b>, and <b>7</b>. Additionally, 3,5-bis(diethyloxycarbonyl)-1,4-DHP amphiphiles comprising substituted pyridinio moieties in positions 2 and 6 (compounds <b>2</b>â€"<b>5</b>) have moderate cytotoxicity, around 3300â€‰mg/kg. In most cases, for the 3,5-bis(diethyloxycarbonyl)-1,4-DHP compounds, it was not possible to calculate IC<sub>50</sub> values for the cancer cell lines HT-1080 and MH-22A due to rather low cytotoxicities; calculated LD<sub>50</sub> values of compounds <b>1</b>â€"<b>9</b> were &amp;gt;2000â€‰mg/kg (for NIH3T3 cells).</p> <p>On the contrary, analogues comprising dodecyl chains in the ester groups at positions 3 and 5 and pyridinium moieties in positions 2 and 6 of the dihydropyridine ring (see comp. <b>10</b> versus comp. <b>1</b>, comp. <b>12</b> versus comp. <b>2</b>, comp. <b>13</b> versus comp. <b>4</b>) showed significant cytotoxicity towards cancer cell lines HT-1080 and MH-22A and still very low cytotoxicity in noncancerous NIH3T3 cells. For example, LD<sub>50</sub> values for compounds <b>10</b>, <b>12</b>, and <b>13</b> were 1482, 1431, and 1706â€‰mg/kg, respectively, while cytotoxicity towards HT-1080 cells was 3â€"10â€‰<i>Î¼</i>g/ml and towards MH-22A cells was 3â€"40â€‰<i>Î¼</i>g/ml. In principle, the obtained data coincide with observations on the impact of dihydropyridine on cell growth, where it was concluded that a long alkyl chain containing 1,4-DHP amphiphiles show promising dual activityâ€"proliferation inhibition on cancer cell lines and proliferation stimulating effect on normal cell lines [<a href="#B31">31</a>]. It should be noted that the 3,5-bis(dodecyloxycarbonyl)-1,4-DHP amphiphile <b>14</b> with an electron-withdrawing acetyl group in the pyridinium moieties in positions 2 and 6 of the 1,4-DHP ring was practically nontoxic on noncancerous NIH3T3 cells and demonstrated selective cytotoxicity toward cancer cells and pronounced cytotoxicity of around 3â€‰<i>Î¼</i>g/ml on HT-1080 cells and of 50-100â€‰<i>Î¼</i>g/ml on MH-22A cells.</p> <p>Substitution of fluorine for hydrogen atoms in alkyl chains of the 1,4-DHP amphiphiles decreased cytotoxicity of the abovementioned compounds. Thus, substitution of the 3,5-dodecyloxycarbonyl alkyl chain's most distant hydrogen atom by trifluoromethyl groups (comp. <b>22</b> versus comp. <b>10</b>) leads to lower cytotoxicity to cancer cell lines HT-1080 (10â€"18â€‰<i>Î¼</i>g/ml versus 3â€‰<i>Î¼</i>g/ml) and MH-22A (10â€"19â€‰<i>Î¼</i>g/ml versus 3â€"6â€‰<i>Î¼</i>g/ml) and to higher cytotoxicity to noncancerous cell line NIH3T3 (771â€‰mg/kg versus 1482â€‰mg/kg). In this case, the influence of the anion was not taken into account, but that also could give an effect. Substitution of seven methylene groups of a 3-dodecyloxy moiety by seven difluoromethylene groups leads to the formation of an unsymmetrical 1,4-DHP amphiphile <b>23</b>, which has lower cytotoxicity to the studied cancer and normal cell lines (comp. <b>23</b> versus comp. <b>10</b>)â€"a cytotoxicity of around 47â€"75â€‰<i>Î¼</i>g/ml versus 3â€"6â€‰<i>Î¼</i>g/ml on cancer cell lines and LD<sub>50</sub> 3448â€‰mg/kg versus 1482â€‰mg/kg, respectively. Further substitution of the next seven methylene groups by seven difluoromethylene groups (comp. <b>24</b>) leads to subsequent diminishing of cytotoxicity to cancer cell lines (around 100â€‰<i>Î¼</i>g/ml) and also low calculated toxicity to noncancerous cell line NIH3T3 (&amp;gt;2000â€‰mg/kg). In the case of the more extended partially fluorinated 3,5-heptadecafluorononadecyl chains (comp. <b>25</b>), the compounds revealed undetectable toxicity to the two cancer cell lines and also low toxicity to the noncancerous cell line NIH3T3. So, from the obtained results (<a href="#tab1">Table 1</a>), it is evident that the perfluorinated 1,4-DHP amphiphiles (compounds <b>23</b>â€"<b>25</b>) are nontoxic in the tested cell lines.</p> <p><i>(2) Modification of Substituents at Position 4 of the 1,4-DHP Ring</i>. Variations of several types of substituents in position 4 of the DHP ring of 3,5-bis(diethyloxycarbonyl)-1,4-DHPs were performed. Compounds with phenyl (comp. <b>1</b>â€"<b>5</b>), substituted phenyl (2-difluoromethylphenyl (comp. <b>7</b> and <b>9</b>), trifluoromethyl (comp. <b>6</b>)), and ethoxycarbonyl (comp. <b>8</b>) substituents were obtained, but no significant influence on the cytotoxicity of the tested 1,4-DHP amphiphiles was observed. Introducing an HO-substituent in a phenyl moiety in position 4 of the 1,4-DHP ring gives comp. <b>18</b> and <b>19</b> which are 4-(4â€²-hydroxyphenyl) analogues of corresponding 4-phenyl-DHPs <b>10</b> and <b>12</b>, respectively. It was demonstrated that the introduction of an HO-substituent does not give a strong influence on the cytotoxicity of the compounds.</p> <p><i>(3) Modification of the Cationic Moieties</i>. Modification of the cationic moieties in positions 2 and 6 of the 1,4-DHP ring (in the case of 3,5-dodecyloxycarbonyl substituents) may result in substantially different toxicological properties. The insertion of substituents in the pyridinium ring leads to some quantitative modifications of cytotoxicityâ€"mainly to slightly diminished cytotoxicity in the case of 4-methyl and 4-dimethylamino substituents (comp. <b>12</b> and comp. <b>13</b>)â€"while introducing a 3-acyl substituent (comp. <b>14</b> versus comp. <b>10</b>) in the pyridinium moiety did not give any influence on the cytotoxicity in HT-1080 cells (in both cases around 3â€‰<i>Î¼</i>g/ml), but decreased cytotoxicity in MH-22A cells (50â€"100â€‰<i>Î¼</i>g/ml and 3â€"6â€‰<i>Î¼</i>g/ml, respectively) and also decreased cytotoxicity in noncancerous cell line NIH3T3 (4040â€‰mg/kg versus 1482â€‰mg/kg). Comparison of the cytotoxicity of the compounds with 4-methylpyridinium and 4-trifluoromethyl pyridinium moieties (comp. <b>12</b> versus comp. <b>21</b>) showed that there are no significant changes of cytotoxicity in cancer HT-1080 and MH-22A cells (5â€"10â€‰<i>Î¼</i>g/ml versus 2â€"4â€‰<i>Î¼</i>g/ml, and 29â€"40â€‰<i>Î¼</i>g/ml versus 19â€"49â€‰<i>Î¼</i>g/ml, respectively) but a twofold increase of cytotoxicity in noncancerous NIH3T3 cells (1431â€‰mg/kg versus 619â€‰mg/kg). Introduction of a pyrazinium moiety instead of a pyridinium moiety (comp. <b>16</b> versus comp. <b>10</b>) gave a compound which was practically inert to the studied cancer cell lines HT-1080 and MH-22A and was also nontoxic to normal NIH3T3 cells. Exchange of the heteroaromatic pyridinium moieties to saturated heterocyclic moietiesâ€"N-methylmorpholinium fragments (comp. <b>15</b>)â€"led to slightly lower anticancer activity of the compound towards the abovementioned cancer cell lines and comparatively higher cytotoxicity to NIH3T3 cells (979â€‰mg/kg). Also, in this case, the influence of the anion was not taken into account, but it may give an effect (ClO<sub>4</sub><sup>âˆ’</sup> instead of Br<sup>âˆ’</sup>). Introducing N,N-dimethylcyclohexylammonium moieties as the cationic part of the amphiphile gave compound <b>17</b> with less cytotoxicity (23â€"54â€‰<i>Î¼</i>g/ml) on both tested cancer cell lines and an LD<sub>50</sub> value of 1274â€‰mg/kg, while the LD<sub>50</sub> value of compound <b>18</b> with the introduced aliphatic N,N-dimethyl-N-dodecylammonium moieties was 836â€‰mg/kg. It was shown that compound <b>18</b> with aliphatic ammonium fragments was more cytotoxic. The obtained data is in agreement with conclusions by Lv et al. that among the synthetic cationic delivery systems, quaternary ammonium surfactants are more toxic than their analogues with the cationic charge delocalized in a heterocyclic system [<a href="#B45">45</a>].</p> <p><i>(4) Change of the Anions</i>. Insertions of the BF<sub>4</sub><sup>âˆ’</sup> anion instead of the usual Br<sup>âˆ’</sup> anion (comp. <b>11</b> versus comp. <b>10</b>) lead to an increase in basal toxicityâ€"1053 and 1482â€‰mg/kg, respectivelyâ€"but a decrease in cytotoxicity on HT-1080 (around 30â€‰<i>Î¼</i>g/ml and 3â€‰<i>Î¼</i>g/ml, respectively) and MH-22A (30â€‰<i>Î¼</i>g/ml and 3â€"6â€‰<i>Î¼</i>g/ml, respectively) cell lines.</p> <p><i>(5) Change of Dehydrogenation Degree</i>. Lipid-like pyridine derivative <b>27</b>, as the oxidized form of compound <b>10</b>, demonstrated very close cytotoxicity data to the corresponding dihydro compound <b>10</b>, in all cases around 3â€‰<i>Î¼</i>g/ml, while basal toxicity on noncancerous cell line NIH3T3 is significantly diminished: comp. <b>27</b> is not harmful at all (LD<sub>50</sub> is 3948â€‰mg/kg). In this case also, the influence of the anion was not taken into account, but it may give an effect (ClO<sub>4</sub><sup>âˆ’</sup> instead of Br<sup>âˆ’</sup>).</p> <p><i>(6) The Duplication of Moieties</i>. Synthetic lipid-like compound <b>26</b> was obtained as a â€œdimericâ€� form of compound <b>10</b>, which was proposed as a promising DNA delivery agent. Cytotoxicity data of amphiphiles (comp. <b>26</b> versus comp. <b>10</b>) demonstrated that this structural modification slightly decreased cytotoxicity of the target compound <b>26</b> in both tested cancer HT-1080 and MH-22A cells (12â€"27â€‰<i>Î¼</i>g/ml versus 3â€"6â€‰<i>Î¼</i>g/ml, respectively) and also considerably decreased the LD<sub>50</sub> valueâ€"5164â€‰mg/kg versus 1482â€‰mg/kg.</p> </div> <div class="3.4.2.cationicmoietycontaining3,4-dihydro-2(1h)-pyridones(table2)" title="sec"> <div class="title" tagx="title" title="title">
3.4.2. Cationic Moiety Containing 3,4-Dihydro-2(1<i>H</i>)-pyridones (<a href="#tab2">Table 2</a>)</div> <p><i>(1) Modification of Ester Alkyl Group</i>. Same as in the case of 1,4-DHP amphiphiles also, pyridones with a short alkyl chainâ€"the methyl group in the ester moiety and pyridinium in the cationic part of the molecule (comp. <b>28</b> and <b>29</b>)â€"were inert to tested cancer cells HT-1080 and MH-22A and demonstrated high calculated LD<sub>50</sub>â€‰values &amp;gt; 2000â€‰mg/kg. In the case of comp. <b>29</b>, the influence of the N-substituent in the pyridone and, in the case of comp. <b>28</b>, the influence of substituent in the phenyl moiety at position 4 of the pyridone cycle were not taken into account. Two other methyl estersâ€"comp. <b>33</b> and <b>36</b>â€"demonstrated significant cytotoxicity on all the tested cell lines. This could be explained by the influence of the cationic moiety in the compound.</p> <p>Substitution of fluorine for hydrogen atoms in the alkyl chain of the pyridone amphiphiles did not give a strong influence on the cytotoxicity of the compounds, and it seems that this also was dependent on the cationic moiety and other substituents of the compound. So, in the case of 4-unsubstituted pyridones with the N,N-dimethylcyclohexylammonium moiety, comp. <b>37</b> with hydrogen atoms in the ester moiety and comp. <b>38</b> with fluorine atoms in the ester moiety demonstrated similar cytotoxicity in all of the tested cell lines, while for cytotoxicity of 4-phenyl pyridones with N,N-dimethylcyclohexylammonium moiety, comp. <b>34</b> with hydrogen atoms in the ester moiety versus comp. <b>35</b> with fluorine atoms in the NIH3T3 cells was two times higher (346 mg/kg versus 898 mg/kg, respectively).</p> <p><i>(2) Modification of Substituents at Position 4 of 3,4-Dihydro-2(1H)-pyridone Ring</i>. The series of 3,4-dihydro-2(1<i>H</i>)-pyridones with a phenyl substituent at position 4 of the pyridone ring and also the 4-unsubstituted ones were compared. In the case of 4-phenyl pyridone <b>34</b> and 4-unsubstituted pyridone <b>37</b>, both compounds containing the same N,N-dimethylcyclohexylammonium moiety and hydrogen atoms in the alkyl chain had no significant change of cytotoxicity on the tested cell lines. While in the case of 4-phenyl pyridone <b>35</b> and 4-unsubstituted pyridone <b>38</b>, both compounds containing the same N,N-dimethylcyclohexylammonium moiety and fluorine atoms in the alkyl chain, the 4-unsubstituted <b>38</b> possessed a slightly higher cytotoxicityâ€"LD<sub>50</sub> values were 553â€‰mg/kg for comp. <b>38</b> and 898â€‰mg/kg for comp. <b>35</b>.</p> <p><i>(3) Change of the Anion</i>. Change to perchlorate from the usual bromine anion (comp. <b>32</b> versus comp. <b>31</b>) did not give any influence on cytotoxicity on the tested cell lines.</p> <p><i>(4) Modification of the Cationic Moiety</i>. It is demonstrated that the dihydropyridone amphiphile <b>30</b> with a triphenylphosphonium polar head group was about 3 times less cytotoxic than the analogous dihydropyridone <b>31</b> with a pyridinium head group in the NIH3T3 cells, i.e., 1779â€‰mg/kg versus 604â€‰mg/kg. Change of pyridinium to N,N-dimethylcyclohexylammonium moiety as the cationic head group of dihydropyridoneâ€"comp. <b>31</b> versus comp. <b>35</b>â€"led to a slightly diminished cytotoxicity on cells in the case of comp. <b>35</b>. In this case, we observed the opposite relationship as for 1,4-DHP amphiphiles where it was demonstrated that quaternary ammonium surfactants are more toxic than their heterocyclic analogues. Toxicity of cationic lipids may be connected with the structure of their head groups [<a href="#B41">41</a>].</p> <p>The obtained data demonstrated that the 3,4-dihydro-2(1<i>H</i>)-pyridone amphiphiles (<a href="#tab2">Table 2</a>) with a pyridinium polar head group and introduced fluorine atoms in the ester moiety (comp. <b>31</b> and comp. <b>32</b>) were substantially more cytotoxic to tested cells than the structurally related 1,4-DHP amphiphiles <b>23</b> and <b>24</b>.</p> <p>Most dihydropyridone series cationic amphiphiles show marked cytotoxicity towards cancer cells and medium cytotoxicity towards normal NIH3T3 cells: compounds possessing 1 or 2 long alkyl chains in ester and/or ammonium groups (with or without fluorine atoms on alkyl chains (comp. <b>31</b>â€"<b>34</b> and <b>36</b>â€"<b>38</b>)). There is an exclusion: comp. <b>30</b> possessing the triphenylphosphonium cationic group.</p> <p>The obtained data allows one to choose compounds for putative use depending on their structure. Thus, due to the polyfluorinated alkyl ester groups in the DHP molecule, low toxicity (practically inert) amphiphilic compounds can be obtained (comp. <b>25</b>). Inert amphiphilic self-assembling compounds could be used as materials to form gene transfection or drug delivery nanoparticles for transmembrane transport according to the paradigm: pharmacologically inert transport vehicles should be used.</p> </div> <div class="3.4.3.2-amino-3-alkoxycarbonylalkylammoniumhalides(table3)" title="sec"> <div class="title" tagx="title" title="title">
3.4.3. 2-Amino-3-alkoxycarbonylalkylammonium Halides (<a href="#tab3">Table 3</a>)</div> <p>The last group of delivery systems was formed by a 2-amino-3-alkoxycarbonylalkylammonium cationic moiety containing derivatives <b>39</b>â€"<b>48</b>.</p> <p><i>(1) Modification of the Cationic Moiety</i>. The cationic moiety was changed for 2-amino-3-hexadecyloxycarbonylammonium derivatives, namely, comp. <b>39</b>â€"<b>43</b>, and <b>45</b>. The obtained data demonstrated that N-(2-amino-4-(hexadecyloxy)-4-oxobut-2-en-1-yl)-N,N-dimethylcyclohexanaminium chloride (comp. <b>39</b>) shows the highest cytotoxicity in all the tested cell lines with a LD<sub>50</sub> value of 97â€‰mg/kg, while alkyl moiety containing compoundsâ€"N-(2-amino-4-(hexadecyloxy)-4-oxobut-2-en-1-yl)-N,N-dimethylhexan-1-aminium chloride (comp. <b>43</b>) and N-(2-amino-4-(hexadecyloxy)-4-oxobut-2-en-1-yl)-N,N-dimethyldodecan-1-aminium chloride (comp. <b>45</b>)â€"demonstrated lower cytotoxicity in all the tested cell lines with LD<sub>50</sub> values of 538 and 573â€‰mg/kg, respectively.</p> <p><i>(2) Modification of the Ester Alkyl Groups</i>. The influence of the alkyl moiety was compared for two amphiphilesâ€"comp. <b>48</b> with decyl ester versus comp. <b>45</b> with hexadecyl ester. The obtained LD<sub>50</sub> data show that the difference is not largeâ€"485â€‰mg/kg versus 573â€‰mg/kg, respectively.</p> <p><i>(3) Change of the Anion</i>. The anions from the usual bromide comp. <b>44</b> were changed to chloride and also to iodide (comp. <b>45</b> and comp. <b>46</b>). According to IC<sub>50</sub> and LD<sub>50</sub> data, the change of the anion did not have any influence on the cytotoxicity in NIH3T3 cell lines; IC<sub>50</sub> values were around 30â€‰<i>Î¼</i>g/ml.</p> </div> </div> <div class="3.5.electrochemicaloxidation" title="sec"> <div class="title" tagx="title" title="title">
3.5. Electrochemical Oxidation</div> <p>The electrochemical oxidation of various 1,4-dihydropyridine derivatives has been extensively studied [<a href="#B46">46</a>â€"<a href="#B50">50</a>] including 1,4-DHP derivatives containing cationic moieties [<a href="#B29">29</a>, <a href="#B44">44</a>]. The electrochemical oxidation of the selected compounds studied in this work was performed by cyclic voltammetry on a stationary glassy carbon electrode in dry acetonitrile; the data is presented in <a href="#tab4">Table 4</a>. The perchlorates of the tested amphiphiles were obtained from the corresponding bromides by treating their abs. MeOH solutions with excess of conc. HClO<sub>4</sub> according to the procedure elaborated by Turovska et al. [<a href="#B44">44</a>].</p> <p>Now, we have used electrooxidation potentials to characterize electron donor properties of the studied compounds.</p> <p>Compounds from the 1st group, containing cationic pyridinium methylene groups in positions 2 and 6 in the 1,4-DHP ring, have electrooxidation potentials of 1.57â€"1.58â€‰V both in the case of 3,5-diethoxycarbonyl- and 3,5-didodecyloxycarbonyl-1,4-DHPs (comp. <b>1</b> and comp. <b>10</b>). This is also in agreement with our previous results, where the electrochemical oxidation potential of comp. <b>1</b> was determined as 1.7â€‰V and electrochemical oxidation of this compound was demonstrated as a two-electron process [<a href="#B29">29</a>]. Introduction of the CF<sub>3</sub> groups at the <i>É·</i>-carbon atom of a dodecyl chain in the ester moieties (comp. <b>18</b>) does not change the value of the electrooxidation potential, which is also 1.57â€‰V. On the contrary, the addition of a CF<sub>3</sub> group in the pyridinium moiety in the 2 and 6 positions of the 1,4-DHP cycle (comp. <b>21</b>) leads to a slight increase of the electrooxidation potential (1.63â€‰V). Moreover, a change of the 17 terminal H atoms to F atoms in one or both dodecyl chains leads to a further increase of the electrooxidation potential of 1.69â€"1.70â€‰V (comp. <b>23</b> and comp. <b>24</b>). It should be noted that the parent compoundsâ€"1,4-DHP derivatives without cationic moietiesâ€"demonstrated lower electrooxidation potentials. Thus, 4-phenyl-substituted Hantzsch 1,4-dihydropyridine has a 1.08â€‰V potential on a glassy carbon electrode [<a href="#B50">50</a>] and the other 4-aryl-substituted 1,4-DHPs have 1.11â€‰V potentials [<a href="#B51">51</a>], but 4-monoalkyl-substituted 1,4-dihydropyridines at the same conditions have 1.01â€"1.03â€‰V oxidation potentials [<a href="#B47">47</a>].</p> <p>Compounds from the 2nd groupâ€"amphiphilic 3,4-dihydropyridone derivatives with a pyridinium methylene moiety in position 6â€"have more positive electrooxidation potential. So, the unsubstituted at position 4 pyridone derivative <b>29</b> has an electrooxidation potential of 2.35â€‰V. A compound possessing a phenyl substituent at position 4 and a 5-heptadecylfluorododecylcarboxy moiety in position 5 (comp. <b>38</b>) has a slightly lower oxidation potential (2.04â€‰V), while the parent 4-unsubstituted or 4-phenyl-substituted 3,4-dihydropyridone derivatives without cationic moiety in position 6 have electrooxidation potentials of 1.52â€"1.64â€‰V [<a href="#B52">52</a>].</p> <p>Compounds from the 3rd groupâ€"tested open-chain 2-amino-3-alkoxycarbonylalkylammonium halides <b>42</b> and <b>44</b>â€"have oxidation potentials of 1.49â€‰V and 1.24â€‰V, respectively.</p> <p>Compounds from the 1st group (comp. <b>1</b>â€"<b>24</b>, <a href="#tab1">Table 1</a>) could be considered as analogues of 1,4-dihydronicotinamide and model compounds of redox coenzyme NAD(P)H. Many 4-aryl-1,4-DHPs possess antioxidant properties, including several Ca<sup>2+</sup> channel blockers [<a href="#B53">53</a>]. The antiradical activity (ARA) of two 1,4-DHPs containing cationic moieties was determined by a 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical assay; the results were expressed as a percentage (%) of the DPPH free radical scavenging, and the untreated level of the DPPH radical was designated as 100% [<a href="#B13">13</a>, <a href="#B31">31</a>]. It was demonstrated that 3,5-didodecyloxycarbonyl-4-phenyl-1,4-dihydropyridine derivatives containing pyridinium moieties showed 25â€"60% radical scavenging activity which are comparable with the ARA of Diludin [<a href="#B54">54</a>] (40%)â€"a widely known antioxidant. Other 1,4-DHP amphiphiles containing saturated heterocyclic moietiesâ€"N-methylmorpholinium or N-methylpyrrolidinium derivativesâ€"demonstrated more pronounced ARA, 95% and 54%, respectively. For 1,4-DHP amphiphiles possessing pyridinium moieties, the positive charge is delocalized in the heteroaromatic cycle, causing ARA reduction; for example, the electron donor dimethylamino group as a substituent of pyridinium moiety leads to a lower ARA (27%, comp. <b>13</b>) [<a href="#B13">13</a>].</p> </div> <div class="3.6.determinationoflogpandmoleculartopologicalpolarsurfacearea" title="sec"> <div class="title" tagx="title" title="title">
3.6. Determination of Log<i>P</i> and Molecular Topological Polar Surface Area</div> <p>The lipophilicity of molecules represents their affinity for a lipophilic environment, and the lipophilicity may be expressed as log<i>P</i> [<a href="#B55">55</a>, <a href="#B56">56</a>]. The molecular polar surface area (PSA) is a very useful parameter for the prediction of drug transport properties, and PSA is defined as a sum of the surfaces of polar atoms [<a href="#B57">57</a>]. In practice, medicinal chemists use the PSA to quantify the polarity of drug molecules [<a href="#B58">58</a>]. Data of the calculated topological polar surface area represent the compound's blood-brain barrier permeability [<a href="#B59">59</a>, <a href="#B60">60</a>]. It allows one to plan further activities for the pleiotropic compounds.</p> <p>Lipid-type compounds could be used as biologically active compounds <i>per se</i> or as transport vehicles or additives, so their lipophilicity (log<i>P</i>) and topological polar surface area (TPSA) were calculated, and the data are recorded in <a href="#tab5">Table 5</a>.</p> <p>Log<i>P</i> values which surpass 5, according to Lipinski's Rule of Five, characterize compounds as lipophilic [<a href="#B61">61</a>]. According to the obtained data for lipid-like amphiphiles, in some cases, the values of log<i>P</i> were &amp;lt;5, in particular for compounds <b>1</b>, <b>2</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>28</b>, and <b>29</b>. These compounds comprised short alkyl moieties in the ester groups. Log<i>P</i> values close to 5 were obtained for compounds <b>36</b>, <b>41</b>, <b>42</b>, and <b>47</b>, namely, 4.70, 5.63, 5.44, and 5.40, respectively. Log<i>P</i> values for dicationic 1,4-DHP amphiphiles possessing longer alkyl chains or fluorinated alkyl groups in the ester moieties were determined in the 11â€"24.5 interval, while for long alkyl ester moieties containing 3,4-dihydropyridone amphiphiles, log<i>P</i> values were determined in the 6â€"15 interval. The difference could be due to the number of alkyl groups. Log<i>P</i> values for other open-chain com12pounds were determined in the 6â€"11 interval.</p> <p>Nevertheless, TPSA never surpasses 90, so the compounds are prone to permeate cells; additionally, they can penetrate the blood-brain barrier [<a href="#B62">62</a>]. Among all tested amphiphiles, only for 1,1â€²-((4-(2-(difluoromethoxy)phenyl)-3,5-bis((propoxymethoxy)carbonyl)-1,4-dihydropyridine-2,6-diyl)bis(methylene))bis(pyridin-1-ium) dibromide (comp. <b>7</b>) was the TPSA value higher than 90, i.e., 98.34â€‰Ã…<sup>2</sup>. This could be explained by the influence of the structure components of the compound. TPSA values for the other compounds were defined in accordance with the main fragments of the compound structures. So, for the other 1st group compoundsâ€"dicationic 1,4-DHP amphiphilesâ€"TPSA values were in the 71â€"77â€‰Ã…<sup>2</sup> interval; for the 2nd group compoundsâ€"cationic 3,4-dihydropyridone amphiphilesâ€"TPSA values were in the 50â€"58â€‰Ã…<sup>2</sup> interval with the exception of compound <b>28</b> which had a TPSA value of 67.64â€‰Ã…<sup>2</sup>; and for the 3rd group compoundsâ€"open-chain 2-amino-3-alkoxycarbonylalkylammonium cationic moiety containing amphiphilesâ€"the TPSA values were in the 52â€"56â€‰Ã…<sup>2</sup> interval.</p> </div> </div> <div class="4.conclusions" title="sec"> <div class="title" tagx="title" title="title">
4. Conclusions</div> <p>Polyfunctional self-assembling synthetic lipid-like compounds, such as pharmacological and chemotherapeutical agents, namely, 3,5-dialkoxycarbonyl-1,4-dihydropyridines (1,4-DHPs) comprising pyridinium or ammonium substituents at the 2 and 6 positions; structurally related compounds, derivatives of 3,4-dihydro-2-oxopyridines as isomeric 3,4-dihydropyridine structures with an additional intracyclic carbonyl group; and the N-<i>Î²</i>-carbonylvinylamido system, namely, 2-amino-3-alkoxycarbonylalkylammonium halides as open chain analogues of the first type of the abovementioned compounds, were studied. The main properties and major functions of these compounds are their amphiphilic character, liposome-forming ability, RNA transfection (by self-assembling compounds), antiradical and antioxidant properties, growth regulationâ€"both in malignant and nonmalignant cell typesâ€"anticancer properties due to cytotoxicity, and MDR inhibition [<a href="#B13">13</a>, <a href="#B16">16</a>, <a href="#B27">27</a>, <a href="#B28">28</a>, <a href="#B31">31</a>, <a href="#B33">33</a>].</p> <p>In this work we have demonstrated biological properties of cationic 1,4-dihydropyridine as self-assembling synthetic lipids and dihydropyridones as well as open-chain analogues: their cytotoxicity against cancer cell lines HT-1080 and MH-22A in comparison with cytotoxicity against normal NIH3T3 cells. The obtained data showed that 1,4-DHP derivatives containing cationic moieties in positions 2 and 6 and possessing dodecyl alkyl chains in the ester groups in positions 3 and 5 demonstrated high cytotoxicity on cancer cells HT-1080 and MH-22A, but low cytotoxicity on noncancerous NIH3T3 cells. According to our previous studies, these compounds also demonstrated significant antiradical activity and also gene delivery activity [<a href="#B13">13</a>], and for some of them, reversal of multidrug resistance in murine lymphoma cells [<a href="#B16">16</a>]. Together with antiradical activity, cell growth regulation, multidrug resistance inhibition, nucleic acid delivery, and the polyfunctional (pleiotropic) type of properties of the mentioned compounds open new avenues for their studies and use. According to literature data, liposomes could be used not only to transport biologically active compounds but also to have their own specific biological activity, e.g., to protect cells and encapsulated components against oxidative damage. Liposomes are proposed for the delivery of antioxidants for protection against pathological conditions related to oxidative stress [<a href="#B63">63</a>]. In our case, liposomes could be used <i>per se</i> to protect against oxidative damage.</p> <p>A calculated degree of lipophilicity and TPSA data can be used to choose compounds according to their permeability through membranes, including the blood-brain barrier, to guide them to the proper location. It was demonstrated that membrane permeability in a variety of systems, including model liposome bilayers, various cells, and epidermal tissue, correlated strongly with data regarding hydrocarbon-water partition coefficients [<a href="#B64">64</a>]. TPSA values for selected compounds were defined in accordance with the main fragments of compound structures. The determined log<i>P</i> values were highest for dodecyl ester groups in positions 3 and 5 of the 1,4-DHP and lowest for short alkyl chain containing amphiphiles.</p> <p>This study also revealed the correlation of the cytotoxic effects of 3 groups of structurally related synthetic cationic lipids according to their molecular structures. The results indicated that among the tested compound groups, amphiphiles based on the 1,4-DHP core demonstrated high cytotoxicity in cancer cells HT-1080 and MH-22A, but low cytotoxicity in the noncancerous NIH3T3 cells.</p> <p>The obtained results may serve as guidelines for the development of drug formulations to be used in cancer treatment on the basis of these pleiotropic lipid-like 1,4-DHP amphiphiles.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p>This research was supported by the PostDocLatvia Project Nr.1.1.1.2/VIAA/2/18/371 â€œBifunctional Amphiphilic Lipid-Like Compoundsâ€"Self-Assembling Properties and Biological Activitiesâ€� (to M. Rucins) and EuroNanoMed2 Project INNOCENT â€œInnovative Nanopharmaceuticals: Targeting Breast Cancer Stem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy.â€�</p> </div> <div class="data-availability" title="data-availability"> <div class="title" tagx="title" title="title">
Data Availability</div> <p>The experimental data used to support the findings of this study are available from the corresponding authors upon request.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Conflicts of Interest</div> <p>The authors declare that there is no conflict of interest regarding the publication of this paper.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Materials</div> <div class="local-data" title="local-data"><span class="label" tagx="label" title="label">Supplementary Materials</span> <p>Scheme S1: synthesis of 1,4-dihydropyridine (1,4-DHP) amphiphiles <b>1</b>â€"<b>7</b>, <b>9</b>â€"<b>22</b>, and <b>26</b>. Scheme S2: synthesis of unsymmetrical 1,4-DHP amphiphile <b>23</b>. Scheme S3: synthesis of 3,4-dihydro-2(1<i>H</i>)-pyridone (DHPDO) amphiphiles <b>28</b>â€"<b>38</b>. Scheme S4: synthesis of 2-amino-3-alkoxycarbonylalkylammonium halides <b>39</b>â€"<b>48</b>. Physicochemical characterization of new compounds is provided.</p>  <div class="media" title="media"><a href="8413713.f1.docx">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <li tag="ref"><a name="B1" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Olusanya</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahmad</span><span class="given-names" tagx="given-names" title="given-names">R. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ibegbu</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elkordy</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Liposomal drug delivery systems and anticancer drugs</span><span class="source" tagx="source" title="source"><i>Molecules</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">23</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">p. 907</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/molecules23040907">10.3390/molecules23040907</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29662019">29662019</a></span></span></li> <li tag="ref"><a name="B2" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Inglut</span><span class="given-names" tagx="given-names" title="given-names">C. T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sorrin</span><span class="given-names" tagx="given-names" title="given-names">A. J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuruppu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Immunological and toxicological considerations for the design of liposomes</span><span class="source" tagx="source" title="source"><i>Nanomaterials</i></span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">10</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">p. 190</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/nano10020190">10.3390/nano10020190</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31978968">31978968</a></span></span></li> <li tag="ref"><a name="B3" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carmona-Ribeiro</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Bilayer-forming synthetic lipids: drugs or carriers?</span><span class="source" tagx="source" title="source"><i>Current Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2003</span><span class="volume" tagx="volume" title="volume">10</span><span class="issue" tagx="issue" title="issue">22</span><span class="fpage" tagx="fpage" title="fpage">2425</span><span class="lpage" tagx="lpage" title="lpage">2446</span><span class="pub-id"><a href="https://dx.doi.org/10.2174/0929867033456611">10.2174/0929867033456611</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14529483">14529483</a></span></span></li> <li tag="ref"><a name="B4" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lechanteur</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanna</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duchemin</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Evrard</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mottet</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Piel</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape</span><span class="source" tagx="source" title="source"><i>Nanomaterials</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">5</span><span class="fpage" tagx="fpage" title="fpage">p. 270</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/nano8050270">10.3390/nano8050270</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29695068">29695068</a></span></span></li> <li tag="ref"><a name="B5" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Safety of novel liposomal drugs for cancer treatment: advances and prospects</span><span class="source" tagx="source" title="source"><i>Chemico-Biological Interactions</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">295</span><span class="fpage" tagx="fpage" title="fpage">13</span><span class="lpage" tagx="lpage" title="lpage">19</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cbi.2017.09.006">10.1016/j.cbi.2017.09.006</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28919304">28919304</a></span></span></li> <li tag="ref"><a name="B6" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Milkovic</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siems</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siems</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zarkovic</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer</span><span class="source" tagx="source" title="source"><i>Current Pharmaceutical Design</i></span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">20</span><span class="issue" tagx="issue" title="issue">42</span><span class="fpage" tagx="fpage" title="fpage">6529</span><span class="lpage" tagx="lpage" title="lpage">6542</span><span class="pub-id"><a href="https://dx.doi.org/10.2174/1381612820666140826152822">10.2174/1381612820666140826152822</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25341930">25341930</a></span></span></li> <li tag="ref"><a name="B7" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.-Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Assaraf</span><span class="given-names" tagx="given-names" title="given-names">Y. G.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Modulating ROS to overcome multidrug resistance in cancer</span><span class="source" tagx="source" title="source"><i>Drug Resistance Updates</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">41</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">25</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.drup.2018.11.001">10.1016/j.drup.2018.11.001</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30471641">30471641</a></span></span></li> <li tag="ref"><a name="B8" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sies</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jones</span><span class="given-names" tagx="given-names" title="given-names">D. P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span><span class="source" tagx="source" title="source"><i>Nature Reviews. Molecular Cell Biology</i></span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">21</span><span class="issue" tagx="issue" title="issue">7</span><span class="fpage" tagx="fpage" title="fpage">363</span><span class="lpage" tagx="lpage" title="lpage">383</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s41580-020-0230-3">10.1038/s41580-020-0230-3</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32231263">32231263</a></span></span></li> <li tag="ref"><a name="B9" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sies</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Oxidative stress: a concept in redox biology and medicine</span><span class="source" tagx="source" title="source"><i>Redox Biology</i></span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">4</span><span class="fpage" tagx="fpage" title="fpage">180</span><span class="lpage" tagx="lpage" title="lpage">183</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.redox.2015.01.002">10.1016/j.redox.2015.01.002</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25588755">25588755</a></span></span></li> <li tag="ref"><a name="B10" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garu</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moku</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gulla</span><span class="given-names" tagx="given-names" title="given-names">S. K.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Examples of tumor growth inhibition properties of liposomal formulations of pH-sensitive histidinylated cationic amphiphiles</span><span class="source" tagx="source" title="source"><i>ACS Biomaterials Science &amp;amp; Engineering</i></span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">1</span><span class="issue" tagx="issue" title="issue">8</span><span class="fpage" tagx="fpage" title="fpage">646</span><span class="lpage" tagx="lpage" title="lpage">655</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acsbiomaterials.5b00025">10.1021/acsbiomaterials.5b00025</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B11" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fasili</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mehri</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ebrahimi</span><span class="given-names" tagx="given-names" title="given-names">H. A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Applying nanoparticles in the treatment of viral infections and toxicological considerations</span><span class="source" tagx="source" title="source"><i>Pharmaceutical and Biomedical Research</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">5</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">20</span><span class="comment"><a href="http://pbr.mazums.ac.ir/article-1-247-en.html">http://pbr.mazums.ac.ir/article-1-247-en.html</a></span></span></li> <li tag="ref"><a name="B12" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barar</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Omidi</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals</span><span class="source" tagx="source" title="source"><i>BioImpacts: BI</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">3</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">105</span><span class="lpage" tagx="lpage" title="lpage">109</span><span class="pub-id"><a href="https://dx.doi.org/10.5681/bi.2013.028">10.5681/bi.2013.028</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24163801">24163801</a></span></span></li> <li tag="ref"><a name="B13" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hyvonen</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petrichenko</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Gene delivery agents possessing antiradical activity: self-assembling cationic amphiphilic 1,4-dihydropyridine derivatives</span><span class="source" tagx="source" title="source"><i>New Journal of Chemistry</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">37</span><span class="issue" tagx="issue" title="issue">10</span><span class="fpage" tagx="fpage" title="fpage">3062</span><span class="lpage" tagx="lpage" title="lpage">3075</span><span class="pub-id"><a href="https://dx.doi.org/10.1039/C3NJ00272A">10.1039/C3NJ00272A</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B14" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petrichenko</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vezane</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Studies of the physicochemical and structural properties of self-assembling cationic pyridine derivatives as gene delivery agents</span><span class="source" tagx="source" title="source"><i>Chemistry and Physics of Lipids</i></span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">191</span><span class="fpage" tagx="fpage" title="fpage">25</span><span class="lpage" tagx="lpage" title="lpage">37</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.chemphyslip.2015.08.005">10.1016/j.chemphyslip.2015.08.005</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26272034">26272034</a></span></span></li> <li tag="ref"><a name="B15" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Apsite</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Timofejeva</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vezane</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and comparative evaluation of novel cationic amphiphile C12-Man-Q as an efficient DNA delivery agent in vitro</span><span class="source" tagx="source" title="source"><i>Molecules</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">23</span><span class="issue" tagx="issue" title="issue">7</span><span class="fpage" tagx="fpage" title="fpage">p. 1540</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/molecules23071540">10.3390/molecules23071540</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29949910">29949910</a></span></span></li> <li tag="ref"><a name="B16" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cindric</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cipak</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Serly</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative</span><span class="source" tagx="source" title="source"><i>Anticancer Research</i></span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">30</span><span class="issue" tagx="issue" title="issue">10</span><span class="fpage" tagx="fpage" title="fpage">4063</span><span class="lpage" tagx="lpage" title="lpage">4069</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21036720">21036720</a></span></span></li> <li tag="ref"><a name="B17" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dubur</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">VÄ«gante</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Dihydropyridine derivatives as bioprotectors</span><span class="source" tagx="source" title="source"><i>Chimica Oggi</i></span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">26</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">68</span><span class="lpage" tagx="lpage" title="lpage">70</span></span></li> <li tag="ref"><a name="B18" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dimitrijevs</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Contribution of molecular structure to self-assembling and biological properties of bifunctional lipid-like 4-(N-alkylpyridinium)-1,4-dihydropyridines</span><span class="source" tagx="source" title="source"><i>Pharmaceutics.</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">p. 115</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/pharmaceutics11030115">10.3390/pharmaceutics11030115</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30871041">30871041</a></span></span></li> <li tag="ref"><a name="B19" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaldre</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and studies of calcium channel blocking and antioxidant activities of novel 4-pyridinium and/or N-propargyl substituted 1,4-dihydropyridine derivatives</span><span class="source" tagx="source" title="source"><i>Comptes Rendus Chimie</i></span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">17</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">69</span><span class="lpage" tagx="lpage" title="lpage">80</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.crci.2013.07.003">10.1016/j.crci.2013.07.003</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B20" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petrova</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muhamadejev</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vigante</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Intramolecular C-Hâ‹¯O hydrogen bonding in 1,4-dihydropyridine derivatives</span><span class="source" tagx="source" title="source"><i>Molecules</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">16</span><span class="issue" tagx="issue" title="issue">9</span><span class="fpage" tagx="fpage" title="fpage">8041</span><span class="lpage" tagx="lpage" title="lpage">8052</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/molecules16098041">10.3390/molecules16098041</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21931285">21931285</a></span></span></li> <li tag="ref"><a name="B21" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saotome</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morita</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Umeda</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs</span><span class="source" tagx="source" title="source"><i>Toxicology in Vitro</i></span><span class="year" tagx="year" title="year">1989</span><span class="volume" tagx="volume" title="volume">3</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">317</span><span class="lpage" tagx="lpage" title="lpage">321</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/0887-2333(89)90039-8">10.1016/0887-2333(89)90039-8</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20702298">20702298</a></span></span></li> <li tag="ref"><a name="B22" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stokes</span><span class="given-names" tagx="given-names" title="given-names">W. S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Casati</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Strickland</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paris</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Neutral red uptake cytotoxicity tests for estimating starting doses for acute oral toxicity tests</span><span class="source" tagx="source" title="source"><i>Current Protocols in Toxicology</i></span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">36</span><span class="issue" tagx="issue" title="issue">1</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/0471140856.tx2004s36">10.1002/0471140856.tx2004s36</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B23" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="collab'">collab: Interagency Coordinating Committee on the Validation of Alternative Methods</span><span class="source" tagx="source" title="source"><i>ICCVAM test method evaluation report (TMER): in vitro cytotoxicity test methods for estimating starting doses for acute oral systemic toxicity testing</i></span><span class="year" tagx="year" title="year">2006</span><span class="comment">NIH Publication No: 07-4519</span></span></li> <li tag="ref"><a name="B24" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="collab'">collab: The national toxicology program (NTP) Interagency center for the evaluation of alternative toxicological methods (NICEATM)</span><span class="source" tagx="source" title="source"><i>Background review document: in vitro cytotoxicity test methods for estimating acute oral systemic toxicity</i></span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">1</span><span class="comment">June 2020 <a href="https://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol1_nov2006.pdf">https://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol1_nov2006.pdf</a></span></span></li> <li tag="ref"><a name="B25" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="collab'">collab: The national toxicology program (NTP) Interagency center for the evaluation of alternative toxicological methods (NICEATM)</span><span class="source" tagx="source" title="source"><i>Background review document: in vitro cytotoxicity test methods for estimating acute oral systemic toxicity</i></span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">2</span><span class="comment">June 2020 <a href="https://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol2_nov2006.pdf">https://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol2_nov2006.pdf</a></span></span></li> <li tag="ref"><a name="B26" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="collab'">collab: EP</span><span class="source" tagx="source" title="source"><i>Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC)</i></span><span class="year" tagx="year" title="year">2008</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Publications office of the European Union</span><span class="comment">doi:2004R0726 - v.7 of 05.06.2013</span></span></li> <li tag="ref"><a name="B27" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ApsÄ«te</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bisenieks</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">BrÅ«vere</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="source" tagx="source" title="source"><i>Novel biologically active enaminoester derivatives as agents for chemotherapy, LV15347B</i></span><span class="year" tagx="year" title="year">2019</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Espacenet</span></span></li> <li tag="ref"><a name="B28" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">HyvÃ¶nen</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reine</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chekavichus</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duburs</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Urtti</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery</span><span class="source" tagx="source" title="source"><i>Biochimica et Biophysica Acta (BBA) - Biomembranes</i></span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">1509</span><span class="issue" tagx="issue" title="issue">1-2</span><span class="fpage" tagx="fpage" title="fpage">451</span><span class="lpage" tagx="lpage" title="lpage">466</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0005-2736(00)00327-8">10.1016/S0005-2736(00)00327-8</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11118554">11118554</a></span></span></li> <li tag="ref"><a name="B29" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaldre</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Oxidation of cationic 1,4-dihydropyridine derivatives as model compounds for putative gene delivery agents</span><span class="source" tagx="source" title="source"><i>Tetrahedron</i></span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">65</span><span class="issue" tagx="issue" title="issue">40</span><span class="fpage" tagx="fpage" title="fpage">8344</span><span class="lpage" tagx="lpage" title="lpage">8349</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tet.2009.08.012">10.1016/j.tet.2009.08.012</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B30" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krivicka</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="source" tagx="source" title="source"><i>The synthesis of new cationic 1,4-dihydropyridine derivatives for DNA delivery, Rigas Teh. Univ. Zinat. Raksti, Ser. 1 Materialzinat. Un Lietiska Kim</i></span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">11</span><span class="fpage" tagx="fpage" title="fpage">7</span><span class="lpage" tagx="lpage" title="lpage">10</span><span class="comment">July 2020 <a href="https://ortus.rtu.lv/science/lv/publications/6433">https://ortus.rtu.lv/science/lv/publications/6433</a></span></span></li> <li tag="ref"><a name="B31" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruvere</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bisenieks</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poikans</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Dihydropyridine derivatives as cell growth modulators in vitro</span><span class="source" tagx="source" title="source"><i>Oxidative Medicine and Cellular Longevity</i></span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">2017</span><span class="fpage" tagx="fpage" title="fpage">15</span><span class="pub-id"><a href="https://dx.doi.org/10.1155/2017/4069839">10.1155/2017/4069839</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28473879">28473879</a></span></span></li> <li tag="ref"><a name="B32" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muhamadejev</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petrova</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smits</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Study of interactions of mononucleotides with 1,4-dihydropyridine vesicles using NMR and ITC techniques</span><span class="source" tagx="source" title="source"><i>New Journal of Chemistry</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">42</span><span class="issue" tagx="issue" title="issue">9</span><span class="fpage" tagx="fpage" title="fpage">6942</span><span class="lpage" tagx="lpage" title="lpage">6948</span><span class="pub-id"><a href="https://dx.doi.org/10.1039/c8nj00160j">10.1039/c8nj00160j</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B33" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smits</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goncharenko</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vesere</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and self-assembly of novel fluorous cationic amphiphiles with a 3,4-dihydro-2(1H)-pyridone spacer</span><span class="source" tagx="source" title="source"><i>Journal of Fluorine Chemistry</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">132</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">414</span><span class="lpage" tagx="lpage" title="lpage">419</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/J.JFLUCHEM.2011.04.008">10.1016/J.JFLUCHEM.2011.04.008</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B34" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sobolev</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Data for the synthesis and characterisation of 2,6-di(bromomethyl)-3,5-bis(alkoxycarbonyl)-4-aryl-1,4-dihydropyridines as important intermediates for synthesis of amphiphilic 1,4-dihydropyridines</span><span class="source" tagx="source" title="source"><i>Data in Brief</i></span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">30</span><span class="fpage" tagx="fpage" title="fpage">p. 105532</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.dib.2020.105532">10.1016/j.dib.2020.105532</a></span></span></li> <li tag="ref"><a name="B35" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pajuste</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kore</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Use of pyridinium ionic liquids as catalysts for the synthesis of 3,5-bis(dodecyloxycarbonyl)-1,4-dihydropyridine derivative</span><span class="source" tagx="source" title="source"><i>Central European Journal of Chemistry</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">9</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">143</span><span class="lpage" tagx="lpage" title="lpage">148</span><span class="pub-id"><a href="https://dx.doi.org/10.2478/s11532-010-0132-x">10.2478/s11532-010-0132-x</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B36" /><span class="label" tagx="label" title="label">36</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nantermet</span><span class="given-names" tagx="given-names" title="given-names">P. G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barrow</span><span class="given-names" tagx="given-names" title="given-names">J. C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Selnick</span><span class="given-names" tagx="given-names" title="given-names">H. G.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Selective <i>Î±</i>1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones</span><span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry Letters</i></span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">10</span><span class="issue" tagx="issue" title="issue">15</span><span class="fpage" tagx="fpage" title="fpage">1625</span><span class="lpage" tagx="lpage" title="lpage">1628</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0960-894X(99)00696-4">10.1016/S0960-894X(99)00696-4</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10937710">10937710</a></span></span></li> <li tag="ref"><a name="B37" /><span class="label" tagx="label" title="label">37</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goodman</span><span class="given-names" tagx="given-names" title="given-names">K. B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dowdell</span><span class="given-names" tagx="given-names" title="given-names">S. E.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Development of dihydropyridone indazole amides as selective rho-kinase inhibitors</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">50</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">6</span><span class="lpage" tagx="lpage" title="lpage">9</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm0609014">10.1021/jm0609014</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17201405">17201405</a></span></span></li> <li tag="ref"><a name="B38" /><span class="label" tagx="label" title="label">38</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Broadbent</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dvorak</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">S. H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pilot-plant preparation of 3,4-dihydropyridin-2-one derivatives, the core structures of P2X7 receptor antagonists</span><span class="source" tagx="source" title="source"><i>Organic Process Research and Development</i></span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">612</span><span class="lpage" tagx="lpage" title="lpage">616</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/op1000447">10.1021/op1000447</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B39" /><span class="label" tagx="label" title="label">39</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Homan</span><span class="given-names" tagx="given-names" title="given-names">K. T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Larimore</span><span class="given-names" tagx="given-names" title="given-names">K. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elkins</span><span class="given-names" tagx="given-names" title="given-names">J. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Szklarz</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Knapp</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tesmer</span><span class="given-names" tagx="given-names" title="given-names">J. J. G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Identification and structure-function analysis of subfamily selective g protein-coupled receptor kinase inhibitors</span><span class="source" tagx="source" title="source"><i>ACS Chemical Biology</i></span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">10</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">310</span><span class="lpage" tagx="lpage" title="lpage">319</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/cb5006323">10.1021/cb5006323</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25238254">25238254</a></span></span></li> <li tag="ref"><a name="B40" /><span class="label" tagx="label" title="label">40</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morales</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ochoa</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SuÃ¡rez</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Novel hexahydrofuro[3,4-b]-2(1H)-pyridones from 4-aryl substituted 5-alkoxycarbonyl-6-methyl-3,4-dihydropyridones</span><span class="source" tagx="source" title="source"><i>J. Heterocycl. Chem.</i></span><span class="year" tagx="year" title="year">1996</span><span class="volume" tagx="volume" title="volume">33</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">103</span><span class="lpage" tagx="lpage" title="lpage">107</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jhet.5570330118">10.1002/jhet.5570330118</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B41" /><span class="label" tagx="label" title="label">41</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vigante</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rucins</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">An efficient synthesis of multisubstituted 4-nitrobuta-1,3-dien-1-amines and application in cyclisation reactions</span><span class="source" tagx="source" title="source"><i>Tetrahedron</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">74</span><span class="issue" tagx="issue" title="issue">21</span><span class="fpage" tagx="fpage" title="fpage">2596</span><span class="lpage" tagx="lpage" title="lpage">2607</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/J.TET.2018.03.075">10.1016/J.TET.2018.03.075</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B42" /><span class="label" tagx="label" title="label">42</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stanovnik</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Enaminone, enaminoesters, and related compounds in the metal-free synthesis of pyridines and fused pyridines</span><span class="source" tagx="source" title="source"><i>European J. Org. Chem.</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">2019</span><span class="issue" tagx="issue" title="issue">31-32</span><span class="fpage" tagx="fpage" title="fpage">5120</span><span class="lpage" tagx="lpage" title="lpage">5132</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/ejoc.201900797">10.1002/ejoc.201900797</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B43" /><span class="label" tagx="label" title="label">43</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barron</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Szoka</span><span class="given-names" tagx="given-names" title="given-names">F. C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">1998</span><span class="volume" tagx="volume" title="volume">41</span><span class="issue" tagx="issue" title="issue">13</span><span class="fpage" tagx="fpage" title="fpage">2207</span><span class="lpage" tagx="lpage" title="lpage">2215</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm950802i">10.1021/jm950802i</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9632353">9632353</a></span></span></li> <li tag="ref"><a name="B44" /><span class="label" tagx="label" title="label">44</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovska</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stradins</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovskis</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shmidlers</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duburs</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Electrochemical oxidation of compounds containing 1,4-dihydropyridine and pyridinium rings - analogs of gene transfection agents</span><span class="source" tagx="source" title="source"><i>Chemistry of Heterocyclic Compounds</i></span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">40</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">753</span><span class="lpage" tagx="lpage" title="lpage">758</span><span class="pub-id"><a href="https://dx.doi.org/10.1023/B:COHC.0000040771.98660.f0">10.1023/B:COHC.0000040771.98660.f0</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B45" /><span class="label" tagx="label" title="label">45</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lv</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Toxicity of cationic lipids and cationic polymers in gene delivery</span><span class="source" tagx="source" title="source"><i>Journal of Controlled Release</i></span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">114</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">100</span><span class="lpage" tagx="lpage" title="lpage">109</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jconrel.2006.04.014">10.1016/j.jconrel.2006.04.014</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16831482">16831482</a></span></span></li> <li tag="ref"><a name="B46" /><span class="label" tagx="label" title="label">46</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baumane</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krauze</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Belyakov</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, structure, and electrochemical characteristics of 4-aryl-2-carbamoylmethylthio-5-ethoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid nitriles</span><span class="source" tagx="source" title="source"><i>Chemistry of Heterocyclic Compounds</i></span><span class="year" tagx="year" title="year">2005</span><span class="volume" tagx="volume" title="volume">41</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">362</span><span class="lpage" tagx="lpage" title="lpage">373</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10593-005-0156-x">10.1007/s10593-005-0156-x</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B47" /><span class="label" tagx="label" title="label">47</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovska</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goba</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovskis</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Electrochemical oxidation of 4-monoalkyl-substituted 1,4-dihydropyridines</span><span class="source" tagx="source" title="source"><i>Chemistry of Heterocyclic Compounds</i></span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">44</span><span class="issue" tagx="issue" title="issue">12</span><span class="fpage" tagx="fpage" title="fpage">1483</span><span class="lpage" tagx="lpage" title="lpage">1490</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10593-009-0211-0">10.1007/s10593-009-0211-0</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B48" /><span class="label" tagx="label" title="label">48</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">NÃºÃ±ez-Vergara</span><span class="given-names" tagx="given-names" title="given-names">L. J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">LÃ³pez-AlarcÃ³n</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Navarrete-Encina</span><span class="given-names" tagx="given-names" title="given-names">P. A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Atria</span><span class="given-names" tagx="given-names" title="given-names">A. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camargo</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Squella</span><span class="given-names" tagx="given-names" title="given-names">J. A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Electrochemical and EPR characterization of 1,4-dihydropyridines. Reactivity towards alkyl radicals</span><span class="source" tagx="source" title="source"><i>Free Radical Research</i></span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">37</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">109</span><span class="lpage" tagx="lpage" title="lpage">120</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/1071576021000036452">10.1080/1071576021000036452</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B49" /><span class="label" tagx="label" title="label">49</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">NÃºÃ±ez-Vergara</span><span class="given-names" tagx="given-names" title="given-names">L. J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Salazar</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camargo</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Oxidation of C4-hydroxyphenyl 1,4-dihydropyridines in dimethylsulfoxide and its reactivity towards alkylperoxyl radicals in aqueous medium</span><span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">15</span><span class="issue" tagx="issue" title="issue">12</span><span class="fpage" tagx="fpage" title="fpage">4318</span><span class="lpage" tagx="lpage" title="lpage">4326</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmc.2007.03.042">10.1016/j.bmc.2007.03.042</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17446078">17446078</a></span></span></li> <li tag="ref"><a name="B50" /><span class="label" tagx="label" title="label">50</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pardo-JimÃ©nez</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barrientos</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">PÃ©rez-Cruz</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and electrochemical oxidation of hybrid compounds: dihydropyridine-fused coumarins</span><span class="source" tagx="source" title="source"><i>Electrochimica Acta</i></span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">125</span><span class="fpage" tagx="fpage" title="fpage">457</span><span class="lpage" tagx="lpage" title="lpage">464</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.electacta.2014.01.137">10.1016/j.electacta.2014.01.137</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B51" /><span class="label" tagx="label" title="label">51</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stradyn</span><span class="given-names" tagx="given-names" title="given-names">Y. P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beilis</span><span class="given-names" tagx="given-names" title="given-names">Y. I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uldrikis</span><span class="given-names" tagx="given-names" title="given-names">Y. R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dubur</span><span class="given-names" tagx="given-names" title="given-names">G. Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sausin</span><span class="given-names" tagx="given-names" title="given-names">A. E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chekavichus</span><span class="given-names" tagx="given-names" title="given-names">B. S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Voltamperometry of 1,4-dihydropyridine derivatives</span><span class="source" tagx="source" title="source"><i>Chemistry of Heterocyclic Compounds</i></span><span class="year" tagx="year" title="year">1975</span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">11</span><span class="fpage" tagx="fpage" title="fpage">1299</span><span class="lpage" tagx="lpage" title="lpage">1303</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/BF00474458">10.1007/BF00474458</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B52" /><span class="label" tagx="label" title="label">52</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smits</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turovska</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Belyakov</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Plotniece</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duburs</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of 5-carboxy-6-methyl-3,4-dihydro-2(1H)-pyridone derivatives and their electrochemical oxidation to 2-pyridones</span><span class="source" tagx="source" title="source"><i>Chemical Physics Letters</i></span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">649</span><span class="fpage" tagx="fpage" title="fpage">84</span><span class="lpage" tagx="lpage" title="lpage">87</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cplett.2016.02.045">10.1016/j.cplett.2016.02.045</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B53" /><span class="label" tagx="label" title="label">53</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Augustyniak</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bartosz</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ÄŒipak</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Natural and synthetic antioxidants: an updated overview</span><span class="source" tagx="source" title="source"><i>Free Radical Research</i></span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">44</span><span class="issue" tagx="issue" title="issue">10</span><span class="fpage" tagx="fpage" title="fpage">1216</span><span class="lpage" tagx="lpage" title="lpage">1262</span><span class="pub-id"><a href="https://dx.doi.org/10.3109/10715762.2010.508495">10.3109/10715762.2010.508495</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20836663">20836663</a></span></span></li> <li tag="ref"><a name="B54" /><span class="label" tagx="label" title="label">54</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tirzitis</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tirzite</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hyvonen</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antioxidant activity of 2,6-dimethyl-3,5-dialkoxycarbonyl-1,4-dihydropyridines in metal-ion catalyzed lipid peroxidation</span><span class="source" tagx="source" title="source"><i>Czech Journal of Food Sciences</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">19</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">81</span><span class="lpage" tagx="lpage" title="lpage">84</span><span class="pub-id"><a href="https://dx.doi.org/10.17221/6581-cjfs">10.17221/6581-cjfs</a></span></span></li> <li tag="ref"><a name="B55" /><span class="label" tagx="label" title="label">55</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wildman</span><span class="given-names" tagx="given-names" title="given-names">S. A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crippen</span><span class="given-names" tagx="given-names" title="given-names">G. M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Prediction of physicochemical parameters by atomic contributions</span><span class="source" tagx="source" title="source"><i>Journal of Chemical Information and Computer Sciences</i></span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">39</span><span class="issue" tagx="issue" title="issue">5</span><span class="fpage" tagx="fpage" title="fpage">868</span><span class="lpage" tagx="lpage" title="lpage">873</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/ci990307l">10.1021/ci990307l</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B56" /><span class="label" tagx="label" title="label">56</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goetz</span><span class="given-names" tagx="given-names" title="given-names">G. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shalaeva</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Leveraging chromatography based physicochemical properties for efficient drug design</span><span class="source" tagx="source" title="source"><i>ADMET DMPK.</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">6</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">85</span><span class="lpage" tagx="lpage" title="lpage">104</span><span class="pub-id"><a href="https://dx.doi.org/10.5599/admet.529">10.5599/admet.529</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B57" /><span class="label" tagx="label" title="label">57</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ertl</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rohde</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Selzer</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">43</span><span class="issue" tagx="issue" title="issue">20</span><span class="fpage" tagx="fpage" title="fpage">3714</span><span class="lpage" tagx="lpage" title="lpage">3717</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm000942e">10.1021/jm000942e</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11020286">11020286</a></span></span></li> <li tag="ref"><a name="B58" /><span class="label" tagx="label" title="label">58</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Caron</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ermondi</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular descriptors for polarity: the need for going beyond polar surface area</span><span class="source" tagx="source" title="source"><i>Future Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">17</span><span class="fpage" tagx="fpage" title="fpage">2013</span><span class="lpage" tagx="lpage" title="lpage">2016</span><span class="pub-id"><a href="https://dx.doi.org/10.4155/fmc-2016-0165">10.4155/fmc-2016-0165</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27739329">27739329</a></span></span></li> <li tag="ref"><a name="B59" /><span class="label" tagx="label" title="label">59</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In silico prediction of blood-brain barrier permeability of compounds by machine learning and resampling methods</span><span class="source" tagx="source" title="source"><i>ChemMedChem</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">13</span><span class="issue" tagx="issue" title="issue">20</span><span class="fpage" tagx="fpage" title="fpage">2189</span><span class="lpage" tagx="lpage" title="lpage">2201</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/cmdc.201800533">10.1002/cmdc.201800533</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30110511">30110511</a></span></span></li> <li tag="ref"><a name="B60" /><span class="label" tagx="label" title="label">60</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benfeito</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oliveira</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fernandes</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction</span><span class="source" tagx="source" title="source"><i>European Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">167</span><span class="fpage" tagx="fpage" title="fpage">525</span><span class="lpage" tagx="lpage" title="lpage">545</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ejmech.2019.01.055">10.1016/j.ejmech.2019.01.055</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30784884">30784884</a></span></span></li> <li tag="ref"><a name="B61" /><span class="label" tagx="label" title="label">61</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipinski</span><span class="given-names" tagx="given-names" title="given-names">C. A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Drug-like properties and the causes of poor solubility and poor permeability</span><span class="source" tagx="source" title="source"><i>Journal of Pharmacological and Toxicological Methods</i></span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">44</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">235</span><span class="lpage" tagx="lpage" title="lpage">249</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S1056-8719(00)00107-6">10.1016/S1056-8719(00)00107-6</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11274893">11274893</a></span></span></li> <li tag="ref"><a name="B62" /><span class="label" tagx="label" title="label">62</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hitchcock</span><span class="given-names" tagx="given-names" title="given-names">S. A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pennington</span><span class="given-names" tagx="given-names" title="given-names">L. D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structure-brain exposure relationships</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">49</span><span class="issue" tagx="issue" title="issue">26</span><span class="fpage" tagx="fpage" title="fpage">7559</span><span class="lpage" tagx="lpage" title="lpage">7583</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm060642i">10.1021/jm060642i</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17181137">17181137</a></span></span></li> <li tag="ref"><a name="B63" /><span class="label" tagx="label" title="label">63</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suntres</span><span class="given-names" tagx="given-names" title="given-names">Z. E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Liposomal antioxidants for protection against oxidant-induced damage</span><span class="source" tagx="source" title="source"><i>Journal of Toxicology</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">2011</span><span class="fpage" tagx="fpage" title="fpage">16</span><span class="pub-id" /><span class="pub-id"><a href="https://dx.doi.org/10.1155/2011/152474">10.1155/2011/152474</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21876690">21876690</a></span></span></li> <li tag="ref"><a name="B64" /><span class="label" tagx="label" title="label">64</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Naylor</span><span class="given-names" tagx="given-names" title="given-names">M. R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ly</span><span class="given-names" tagx="given-names" title="given-names">A. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Handford</span><span class="given-names" tagx="given-names" title="given-names">M. J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Lipophilic permeability efficiency reconciles the opposing roles of lipophilicity in membrane permeability and aqueous solubility</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">61</span><span class="issue" tagx="issue" title="issue">24</span><span class="fpage" tagx="fpage" title="fpage">11169</span><span class="lpage" tagx="lpage" title="lpage">11182</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jmedchem.8b01259">10.1021/acs.jmedchem.8b01259</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30395703">30395703</a></span></span></li> </ul> </div> </div> <div class="floats-group" title="floats-group"> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 1</span></a></div>   <p>Synthesis of 1,4-dihydropyridine (1,4-DHP) amphiphiles <b>1</b>â€"<b>7</b>, <b>9</b>â€"<b>22</b>, and <b>26</b>.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 2</span></a></div>   <p>Synthesis of unsymmetrical 1,4-DHP amphiphile <b>23</b>.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 3</span></a></div>   <p>Synthesis of 3,4-dihydro-2(1<i>H</i>)-pyridone (DHPDO) amphiphiles <b>28-38</b>.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 4</span></a></div>   <p>Synthesis of 2-amino-3-alkoxycarbonylalkylammonium halides <b>39-48</b>.</p>   </div> <div class="table-wrap_UNKNOWN" id="tab1" content-type="sidewaystable" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1</span> <p>Structure, cytotoxicity, and calculated basal toxicity of 1,4-dihydropyridines containing cationic moieties. <span class="inline-graphic" title="inline-graphic" /></p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2" colspan="1">Comp.</th> <th align="center" rowspan="2" colspan="1">Cat<sup>+</sup></th> <th align="center" rowspan="2" colspan="1">R<sup>3</sup></th> <th align="center" rowspan="2" colspan="1">R<sup>4</sup></th> <th align="center" rowspan="2" colspan="1">R<sup>5</sup></th> <th align="center" rowspan="2" colspan="1">X<sup>âˆ’</sup></th> <th align="center" colspan="2" rowspan="1">HT-1080</th> <th align="center" colspan="2" rowspan="1">MH-22A</th> <th align="center" colspan="2" rowspan="1">NIH3T3</th> <th align="center" rowspan="2" colspan="1">Ref.</th> </tr> <tr> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (NR)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">LD<sub>50</sub><br /><br />(mg/kg)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B29">29</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">2</td> <td align="center" rowspan="1" colspan="1">Py-Me-4</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;740</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;3360</td> <td align="center" rowspan="1" colspan="1">[<a href="#B30">30</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">3</td> <td align="center" rowspan="1" colspan="1">Py-NH<sub>2</sub>-4</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">441 Â± 46</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">&amp;gt;740</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;3360</td> <td align="center" rowspan="1" colspan="1">Suppl.</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">4</td> <td align="center" rowspan="1" colspan="1">Py-NMe<sub>2</sub>-4</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">324 Â± 29</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">608 Â± 49</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;3500</td> <td align="center" rowspan="1" colspan="1">Suppl.</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">5</td> <td align="center" rowspan="1" colspan="1">Py-Me-3</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">&amp;gt;740</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;3360</td> <td align="center" rowspan="1" colspan="1">Suppl.</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">6</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-CF<sub>3</sub>-2</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B20">20</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">7</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>4</sub>OC<sub>3</sub>H<sub>7</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-OCHF<sub>2</sub>-2</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>4</sub>OC<sub>3</sub>H<sub>7</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B20">20</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">8</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">COOCH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">I</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B20">20</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">9</td> <td align="center" rowspan="1" colspan="1">N-Me-morph</td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-OCHF<sub>2</sub>-2</td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">ClO<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B31">31</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">10</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.5</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">6 Â± 1</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.8</td> <td align="center" rowspan="1" colspan="1">100 Â± 6</td> <td align="center" rowspan="1" colspan="1">1482</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>, <a href="#B28">28</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">11</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">BF<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">31 Â± 4</td> <td align="center" rowspan="1" colspan="1">28 Â± 9</td> <td align="center" rowspan="1" colspan="1">30 Â± 6</td> <td align="center" rowspan="1" colspan="1">30 Â± 9</td> <td align="center" rowspan="1" colspan="1">47 Â± 8</td> <td align="center" rowspan="1" colspan="1">1053</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">12</td> <td align="center" rowspan="1" colspan="1">Py-Me-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">5 Â± 1</td> <td align="center" rowspan="1" colspan="1">40 Â± 2</td> <td align="center" rowspan="1" colspan="1">29 Â± 2</td> <td align="center" rowspan="1" colspan="1">79 Â± 11</td> <td align="center" rowspan="1" colspan="1">1431</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">13</td> <td align="center" rowspan="1" colspan="1">Py-NMe<sub>2</sub>-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">10 Â± 1</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">6 Â± 2</td> <td align="center" rowspan="1" colspan="1">10 Â± 3</td> <td align="center" rowspan="1" colspan="1">119 Â± 13</td> <td align="center" rowspan="1" colspan="1">1706</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">14</td> <td align="center" rowspan="1" colspan="1">Py-C(=O)CH<sub>3</sub>-3</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">100 Â± 13</td> <td align="center" rowspan="1" colspan="1">49 Â± 9</td> <td align="center" rowspan="1" colspan="1">922 Â± 24</td> <td align="center" rowspan="1" colspan="1">4040</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">15</td> <td align="center" rowspan="1" colspan="1">N-Me-morph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">ClO<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">13 Â± 3</td> <td align="center" rowspan="1" colspan="1">12 Â± 3</td> <td align="center" rowspan="1" colspan="1">34 Â± 11</td> <td align="center" rowspan="1" colspan="1">27 Â± 9</td> <td align="center" rowspan="1" colspan="1">35 Â± 13</td> <td align="center" rowspan="1" colspan="1">979</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">16</td> <td align="center" rowspan="1" colspan="1">Pyr</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">[<a href="#B13">13</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">17</td> <td align="center" rowspan="1" colspan="1">NMe<sub>2</sub>CyHex</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">35 Â± 9</td> <td align="center" rowspan="1" colspan="1">23 Â± 3</td> <td align="center" rowspan="1" colspan="1">54 Â± 16</td> <td align="center" rowspan="1" colspan="1">35 Â± 9</td> <td align="center" rowspan="1" colspan="1">59 Â± 12</td> <td align="center" rowspan="1" colspan="1">1274</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">18</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-OH-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">4.3 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">3.4 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">16 Â± 2</td> <td align="center" rowspan="1" colspan="1">95 Â± 7</td> <td align="center" rowspan="1" colspan="1">1479</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">19</td> <td align="center" rowspan="1" colspan="1">Py-CH<sub>3</sub>-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-OH-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">32 Â± 8</td> <td align="center" rowspan="1" colspan="1">22 Â± 5</td> <td align="center" rowspan="1" colspan="1">21 Â± 3</td> <td align="center" rowspan="1" colspan="1">30 Â± 8</td> <td align="center" rowspan="1" colspan="1">44 Â± 11</td> <td align="center" rowspan="1" colspan="1">1087</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">20</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">19 Â± 6</td> <td align="center" rowspan="1" colspan="1">836</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">21</td> <td align="center" rowspan="1" colspan="1">Py-CF<sub>3</sub>-4</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">4 Â± 0.5</td> <td align="center" rowspan="1" colspan="1">49 Â± 8</td> <td align="center" rowspan="1" colspan="1">19 Â± 6</td> <td align="center" rowspan="1" colspan="1">12 Â± 4</td> <td align="center" rowspan="1" colspan="1">619</td> <td align="center" rowspan="1" colspan="1">[<a href="#B32">32</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">22</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>24</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>24</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">ClO<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">18 Â± 5</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">10 Â± 1</td> <td align="center" rowspan="1" colspan="1">19 Â± 5</td> <td align="center" rowspan="1" colspan="1">16 Â± 3</td> <td align="center" rowspan="1" colspan="1">771</td> <td align="center" rowspan="1" colspan="1">[<a href="#B32">32</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">23</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">50 Â± 6</td> <td align="center" rowspan="1" colspan="1">47 Â± 8</td> <td align="center" rowspan="1" colspan="1">47 Â± 2</td> <td align="center" rowspan="1" colspan="1">75 Â± 11</td> <td align="center" rowspan="1" colspan="1">477 Â± 25</td> <td align="center" rowspan="1" colspan="1">3448</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">24</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">100 Â± 11</td> <td align="center" rowspan="1" colspan="1">100 Â± 9</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">25</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>11</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>11</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">26</td> <td align="center" colspan="4" rowspan="1">â€œDimericâ€� form of comp. <b>10</b></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">12 Â± 4</td> <td align="center" rowspan="1" colspan="1">14 Â± 2</td> <td align="center" rowspan="1" colspan="1">27 Â± 6</td> <td align="center" rowspan="1" colspan="1">21 Â± 4</td> <td align="center" rowspan="1" colspan="1">717 Â± 56</td> <td align="center" rowspan="1" colspan="1">5164</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">27</td> <td align="center" colspan="4" rowspan="1">Oxidated form of comp. <b>10</b></td> <td align="center" rowspan="1" colspan="1">ClO<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">3.2 Â± 0.8</td> <td align="center" rowspan="1" colspan="1">3.1 Â± 0.5</td> <td align="center" rowspan="1" colspan="1">3.0 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">3.3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">900 Â± 42</td> <td align="center" rowspan="1" colspan="1">3946</td> <td align="center" rowspan="1" colspan="1">[<a href="#B14">14</a>]</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>nt: not tested; âˆ—: not detected.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="tab2" content-type="sidewaystable" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2</span> <p>Structure, cytotoxicity, and calculated basal toxicity of 3,4-dihydro-2(1<i>H</i>)-pyridones containing cationic moiety. <span class="inline-graphic" title="inline-graphic" /></p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2" colspan="1">Comp.</th> <th align="center" rowspan="2" colspan="1">R<sup>1</sup></th> <th align="center" rowspan="2" colspan="1">Cat<sup>+</sup></th> <th align="center" rowspan="2" colspan="1">R<sup>3</sup></th> <th align="center" rowspan="2" colspan="1">R<sup>4</sup></th> <th align="center" rowspan="2" colspan="1">X<sup>âˆ’</sup></th> <th align="center" colspan="2" rowspan="1">HT-1080</th> <th align="center" colspan="2" rowspan="1">MH-22A</th> <th align="center" colspan="2" rowspan="1">NIH3T3</th> <th align="center" rowspan="2" colspan="1">Ref.</th> </tr> <tr> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (NR)<br /><br />(<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">LD<sub>50</sub><br /><br />(mg/kg)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">28</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>6</sub>H<sub>4</sub>-OCHF<sub>2</sub>-2</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">&amp;gt;100</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">1132 Â± 85</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">29</td> <td align="center" rowspan="1" colspan="1">PhCH<sub>2</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">âˆ—</td> <td align="center" rowspan="1" colspan="1">972 Â± 27</td> <td align="center" rowspan="1" colspan="1">&amp;gt;2000</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">30</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">PPh<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">10 Â± 2</td> <td align="center" rowspan="1" colspan="1">9 Â± 2</td> <td align="center" rowspan="1" colspan="1">30 Â± 11</td> <td align="center" rowspan="1" colspan="1">39 Â± 5</td> <td align="center" rowspan="1" colspan="1">127 Â± 11</td> <td align="center" rowspan="1" colspan="1">1779</td> <td align="center" rowspan="1" colspan="1">[<a href="#B33">33</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">31</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">3 Â± 1</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">15 Â± 2</td> <td align="center" rowspan="1" colspan="1">604</td> <td align="center" rowspan="1" colspan="1">[<a href="#B33">33</a>]</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">32</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">ClO<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.5</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">15 Â± 3</td> <td align="center" rowspan="1" colspan="1">618</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">33</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.1</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">4 Â± 1</td> <td align="center" rowspan="1" colspan="1">269</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">34</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.8</td> <td align="center" rowspan="1" colspan="1">&amp;lt;1</td> <td align="center" rowspan="1" colspan="1">6 Â± 2</td> <td align="center" rowspan="1" colspan="1">346</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">35</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">30 Â± 11</td> <td align="center" rowspan="1" colspan="1">26 Â± 6</td> <td align="center" rowspan="1" colspan="1">30 Â± 8</td> <td align="center" rowspan="1" colspan="1">27 Â± 9</td> <td align="center" rowspan="1" colspan="1">898</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">36</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">18 Â± 3</td> <td align="center" rowspan="1" colspan="1">16 Â± 3</td> <td align="center" rowspan="1" colspan="1">63 Â± 11</td> <td align="center" rowspan="1" colspan="1">831</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">37</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.5</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">7 Â± 1</td> <td align="center" rowspan="1" colspan="1">369</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">38</td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">4 Â± 0.8</td> <td align="center" rowspan="1" colspan="1">&amp;lt;1</td> <td align="center" rowspan="1" colspan="1">11 Â± 3</td> <td align="center" rowspan="1" colspan="1">553</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>âˆ—: not detected.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="tab3" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3</span> <p>Structures, cytotoxicity, and calculated toxicity of 2-amino-3-alkoxycarbonylalkylammonium halides. <span class="inline-graphic" title="inline-graphic" /></p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2" colspan="1">Comp.</th> <th align="center" rowspan="2" colspan="1">Cat<sup>+</sup></th> <th align="center" rowspan="2" colspan="1">R</th> <th align="center" rowspan="2" colspan="1">X<sup>âˆ’</sup></th> <th align="center" colspan="2" rowspan="1">HT-1080</th> <th align="center" colspan="2" rowspan="1">MH-22A</th> <th align="center" colspan="2" rowspan="1">NIH3T3</th> <th align="center" rowspan="2" colspan="1">Ref.</th> </tr> <tr> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (CV) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (MTT) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (NR) (<i>Î¼</i>g/ml)</th> <th align="center" rowspan="1" colspan="1">LD<sub>50</sub> (mg/kg)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">39</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>CyHex</td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">0.35 Â± 0.06</td> <td align="center" rowspan="1" colspan="1">0.5 Â± 0.1</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">0.2 Â± 0.06</td> <td align="center" rowspan="1" colspan="1">0.7 Â± 0.1</td> <td align="center" rowspan="1" colspan="1">97</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">40</td> <td align="center" rowspan="1" colspan="1">N-Me(CH<sub>2</sub>)<sub>4</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">&amp;lt;1</td> <td align="center" rowspan="1" colspan="1">&amp;lt;1</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">&amp;lt;1</td> <td align="center" rowspan="1" colspan="1">8 Â± 1</td> <td align="center" rowspan="1" colspan="1">312</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">41</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">5 Â± 1</td> <td align="center" rowspan="1" colspan="1">286</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">42</td> <td align="center" rowspan="1" colspan="1">N-Me(CH<sub>2</sub>)<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>Me</td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.1</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">4 Â± 1</td> <td align="center" rowspan="1" colspan="1">237</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">43</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>6</sub>H<sub>13</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.6</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">1 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">21 Â± 6</td> <td align="center" rowspan="1" colspan="1">538</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">44</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Br</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.3</td> <td align="center" rowspan="1" colspan="1">25 Â± 3</td> <td align="center" rowspan="1" colspan="1">28 Â± 6</td> <td align="center" rowspan="1" colspan="1">31 Â± 8</td> <td align="center" rowspan="1" colspan="1">697</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">45</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">25 Â± 9</td> <td align="center" rowspan="1" colspan="1">573</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">46</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">I</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">34 Â± 8</td> <td align="center" rowspan="1" colspan="1">637</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">47</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">I</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.1</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">14 Â± 9</td> <td align="center" rowspan="1" colspan="1">403</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">48</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">C<sub>10</sub>H<sub>21</sub></td> <td align="center" rowspan="1" colspan="1">Cl</td> <td align="center" rowspan="1" colspan="1">3 Â± 0.4</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">2 Â± 0.2</td> <td align="center" rowspan="1" colspan="1">nt</td> <td align="center" rowspan="1" colspan="1">17 Â± 3</td> <td align="center" rowspan="1" colspan="1">485</td> <td align="center" rowspan="1" colspan="1">Suppl</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>nt: not tested.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="tab4" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4</span> <p>Oxidation potentials (E<sup>ox</sup>) of selected compounds.<span class="inline-graphic" title="inline-graphic" /></p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="1" colspan="1">Group</th> <th align="center" rowspan="1" colspan="1">Comp.</th> <th align="center" rowspan="1" colspan="1">R<sup>1</sup></th> <th align="center" rowspan="1" colspan="1">R<sup>3</sup></th> <th align="center" rowspan="1" colspan="1">R<sup>4</sup></th> <th align="center" rowspan="1" colspan="1">R<sup>5</sup></th> <th align="center" rowspan="1" colspan="1">Cat<sup>+</sup></th> <th align="center" rowspan="1" colspan="1">E<sup>ox</sup> (V)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1st</td> <td align="center" rowspan="1" colspan="1"><b>1</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">1.57</td> </tr> <tr> <td rowspan="5" colspan="1" /> <td align="center" rowspan="1" colspan="1"><b>10</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">1.58</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>21</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Py-CF<sub>3</sub>-4</td> <td align="center" rowspan="1" colspan="1">1.63</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>22</b></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>24</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>24</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">1.57</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>23</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">1.70</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>24</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">1.69</td> </tr> <tr> <td align="left" rowspan="2" colspan="1">2nd</td> <td align="center" rowspan="1" colspan="1"><b>29</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">PhCH<sub>2</sub></td> <td align="center" rowspan="1" colspan="1">CH<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">2.35</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>38</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">H</td> <td align="center" rowspan="1" colspan="1">(CH<sub>2</sub>)<sub>4</sub>(CF<sub>2</sub>)<sub>7</sub>CF<sub>3</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">Py</td> <td align="center" rowspan="1" colspan="1">2.04</td> </tr> <tr> <td align="left" rowspan="2" colspan="1">3rd</td> <td align="center" rowspan="1" colspan="1"><b>42</b><sup>âˆ—</sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">N-Me(CH<sub>2</sub>)<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>Me</td> <td align="center" rowspan="1" colspan="1">1.49</td> </tr> <tr> <td align="center" rowspan="1" colspan="1"><b>44</b><sup><b>#</b></sup></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">C<sub>16</sub>H<sub>33</sub></td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">N-Me<sub>2</sub>C<sub>12</sub>H<sub>25</sub></td> <td align="center" rowspan="1" colspan="1">1.24</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p><sup>âˆ—</sup>Original compoundsâ€"bromide; <sup>#</sup>original compoundâ€"chloride.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="tab5" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 5</span> <p>Log<i>P</i> and molecular topological polar surface area (TPSA) of selected compounds.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="center" colspan="3" rowspan="1">1st group</th> <th align="center" colspan="3" rowspan="1">2nd group</th> <th align="center" colspan="3" rowspan="1">3rd group</th> </tr> <tr> <th align="left" rowspan="1" colspan="1">Comp.</th> <th align="center" rowspan="1" colspan="1">Log<i>P</i></th> <th align="center" rowspan="1" colspan="1">TPSA (Ã…<sup>2</sup>)</th> <th align="center" rowspan="1" colspan="1">Comp.</th> <th align="center" rowspan="1" colspan="1">Log<i>P</i></th> <th align="center" rowspan="1" colspan="1">TPSA (Ã…<sup>2</sup>)</th> <th align="center" rowspan="1" colspan="1">Comp.</th> <th align="center" rowspan="1" colspan="1">Log<i>P</i></th> <th align="center" rowspan="1" colspan="1">TPSA (Ã…<sup>2</sup>)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">2.26</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">28</td> <td align="center" rowspan="1" colspan="1">1.44</td> <td align="center" rowspan="1" colspan="1">67.64</td> <td align="center" rowspan="1" colspan="1">39</td> <td align="center" rowspan="1" colspan="1">7.52</td> <td align="center" rowspan="1" colspan="1">52.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">2</td> <td align="center" rowspan="1" colspan="1">3.13</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">29</td> <td align="center" rowspan="1" colspan="1">1.18</td> <td align="center" rowspan="1" colspan="1">49.62</td> <td align="center" rowspan="1" colspan="1">40</td> <td align="center" rowspan="1" colspan="1">6.25</td> <td align="center" rowspan="1" colspan="1">52.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">4</td> <td align="center" rowspan="1" colspan="1">2.71</td> <td align="center" rowspan="1" colspan="1">77.13</td> <td align="center" rowspan="1" colspan="1">30</td> <td align="center" rowspan="1" colspan="1">14.32</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td align="center" rowspan="1" colspan="1">41</td> <td align="center" rowspan="1" colspan="1">5.63</td> <td align="center" rowspan="1" colspan="1">55.56</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">6</td> <td align="center" rowspan="1" colspan="1">3.18</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">31</td> <td align="center" rowspan="1" colspan="1">9.43</td> <td align="center" rowspan="1" colspan="1">58.41</td> <td align="center" rowspan="1" colspan="1">42</td> <td align="center" rowspan="1" colspan="1">5.44</td> <td align="center" rowspan="1" colspan="1">55.56</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">7</td> <td align="center" rowspan="1" colspan="1">3.20</td> <td align="center" rowspan="1" colspan="1">98.34</td> <td align="center" rowspan="1" colspan="1">32</td> <td align="center" rowspan="1" colspan="1">9.43</td> <td align="center" rowspan="1" colspan="1">58.41</td> <td align="center" rowspan="1" colspan="1">43</td> <td align="center" rowspan="1" colspan="1">7.98</td> <td align="center" rowspan="1" colspan="1">52.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">10</td> <td align="center" rowspan="1" colspan="1">10.97</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">33</td> <td align="center" rowspan="1" colspan="1">6.19</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td align="center" rowspan="1" colspan="1">44</td> <td align="center" rowspan="1" colspan="1">10.65</td> <td align="center" rowspan="1" colspan="1">52.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">12</td> <td align="center" rowspan="1" colspan="1">11.63</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">34</td> <td align="center" rowspan="1" colspan="1">10.01</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td align="center" rowspan="1" colspan="1">47</td> <td align="center" rowspan="1" colspan="1">5.40</td> <td align="center" rowspan="1" colspan="1">55.33</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">13</td> <td align="center" rowspan="1" colspan="1">11.42</td> <td align="center" rowspan="1" colspan="1">77.13</td> <td align="center" rowspan="1" colspan="1">35</td> <td align="center" rowspan="1" colspan="1">14.81</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td align="center" rowspan="1" colspan="1">48</td> <td align="center" rowspan="1" colspan="1">7.98</td> <td align="center" rowspan="1" colspan="1">52.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">17</td> <td align="center" rowspan="1" colspan="1">13.55</td> <td align="center" rowspan="1" colspan="1">64.63</td> <td align="center" rowspan="1" colspan="1">36</td> <td align="center" rowspan="1" colspan="1">4.70</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">20</td> <td align="center" rowspan="1" colspan="1">19.81</td> <td align="center" rowspan="1" colspan="1">64.63</td> <td align="center" rowspan="1" colspan="1">37</td> <td align="center" rowspan="1" colspan="1">8.52</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">21</td> <td align="center" rowspan="1" colspan="1">12.81</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td align="center" rowspan="1" colspan="1">38</td> <td align="center" rowspan="1" colspan="1">13.32</td> <td align="center" rowspan="1" colspan="1">55.40</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">22</td> <td align="center" rowspan="1" colspan="1">13.22</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">23</td> <td align="center" rowspan="1" colspan="1">15.77</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">24</td> <td align="center" rowspan="1" colspan="1">18.64</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> <tr> <td align="left" rowspan="1" colspan="1">25</td> <td align="center" rowspan="1" colspan="1">24.68</td> <td align="center" rowspan="1" colspan="1">70.65</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1" /> </tr> </tbody> </table> </div> </div>  </body></html>